A
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, .:
Research Funding
Celgene, .: Research Funding and Speakers Bureau
CIRM, .: Research Funding
BMS, .: Speakers Bureau
Gilead, .: Speakers Bureau
Seattle Genetics, .: Speakers Bureau
Takeda, .: Speakers Bureau
Celgene, .: Research Funding and Speakers Bureau
CIRM, .: Research Funding
BMS, .: Speakers Bureau
Gilead, .: Speakers Bureau
Seattle Genetics, .: Speakers Bureau
Takeda, .: Speakers Bureau
Nothing to Disclose
Therakos, Speakers bureau:
Speakers bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Juno Therapeutics, Research Funding:
Research Funding
Teva, Lecturer: Honoraria
Teva, Lecturer: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Advisory Board:
Advisory Board
Glycomimetics, Consultant: Consultancy
ASH, Honoraria: Honoraria
Leidos/NCI, Honoraria: Honoraria
Pfeizer, Research support: Research Funding
Glycomimetics, Consultant: Consultancy
ASH, Honoraria: Honoraria
Leidos/NCI, Honoraria: Honoraria
Pfeizer, Research support: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kadmon Corporation, LLC, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Karius Inc., Medical Director:
Salary
Nothing to Disclose
Humanigen, Employee:
Employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, Advisory board:
Advisory Board
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
medac, none:
travel support
GSK, consulting: Consultancy and Research Funding
octapharma, speaking: Honoraria and travel support
CSL, speaking: Honoraria
Amgen, none: Ownership Interest
GSK, consulting: Consultancy and Research Funding
octapharma, speaking: Honoraria and travel support
CSL, speaking: Honoraria
Amgen, none: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Abbvie, Consultancy:
Consultancy
Spectrum, Ad Board: Advisory Board
Kite, Ad Board: Advisory Board
Celgene, Ad Board: Advisory Board
Spectrum, Ad Board: Advisory Board
Kite, Ad Board: Advisory Board
Celgene, Ad Board: Advisory Board
Kite Pharma, Inc., Speaker:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte Corporation, Advisory board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Altor BioScience Corporation employment equity ownership, employment:
equity ownership
Nothing to Disclose
Viracor Eurofins, employee:
Salary
Viracor Eurofins Clinical Diagnostics, Chief Scientific Officer, Clinical Laboratory Director:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Optum, Inc, Research:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Adaptive Biotechnologies, Scientific Advisory Board:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, Employee:
Ownership Interest
and
Salary
Cephalon, .:
Research Funding
Nothing to Disclose
Nothing to Disclose
Oxford mmunotec, Research:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi biotech:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
bluebird bio, Inc., employee:
Ownership Interest
and
Salary
bluebird bio, Inc., Employee: Ownership Interest and Salary
bluebird bio, Inc., Employee: Ownership Interest and Salary
Nothing to Disclose
Incyte, Independent Contractor:
Advisory Board
Boston Biomedical, Independent Contractor: Advisory Board
OncLive, Independent Contractor: Honoraria
Boston Biomedical, Independent Contractor: Advisory Board
OncLive, Independent Contractor: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, NA:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, Employment:
Salary
Abbott Laboratories, other:
Honoraria
Celgene, SAB:
Honoraria
BMS, SAB: Honoraria
Juno, SAB: Honoraria
Jannsen, consultant: Honoraria
Kymriah, SAB: Honoraria
pharmacyclics, collaboration: Research Funding
BMS, SAB: Honoraria
Juno, SAB: Honoraria
Jannsen, consultant: Honoraria
Kymriah, SAB: Honoraria
pharmacyclics, collaboration: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
B
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
American Society for Hospital Pharmacy, None:
Honoraria
Gilead Pharmaceuticals, None: Honoraria
WebMD, None: Honoraria
Goldman Sachs, None: Honoraria
Defined Health, None: Honoraria
Vizient, None: Honoraria
Foundation Medicine, None: Consultancy and Honoraria
Anthem, None: Honoraria
Excellus Health Plan, None: Honoraria
Hematology Oncology Pharmacy Assoc, None: Honoraria
Novartis Pharmaceuticals, None: Honoraria
Janssen Pharmaceuticals, None: Honoraria
Third Rock Ventures, None: Honoraria
JMP Securities, None: Honoraria
Grail, None: Consultancy and Honoraria
Gilead Pharmaceuticals, None: Honoraria
WebMD, None: Honoraria
Goldman Sachs, None: Honoraria
Defined Health, None: Honoraria
Vizient, None: Honoraria
Foundation Medicine, None: Consultancy and Honoraria
Anthem, None: Honoraria
Excellus Health Plan, None: Honoraria
Hematology Oncology Pharmacy Assoc, None: Honoraria
Novartis Pharmaceuticals, None: Honoraria
Janssen Pharmaceuticals, None: Honoraria
Third Rock Ventures, None: Honoraria
JMP Securities, None: Honoraria
Grail, None: Consultancy and Honoraria
GAMIDA Cell, NA:
Research Funding
UNUM, NA: Research Funding
Novartis, NA: Advisory Board and Research Funding
GT Biopharma, NA: Research Funding
Gamida Cell, none: Research Funding
UNUM, NA: Research Funding
Novartis, NA: Advisory Board and Research Funding
GT Biopharma, NA: Research Funding
Gamida Cell, none: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
KITE, Member:
Advisory Board
Kite Pharma, Spouse is on advisory board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Advisor, Presenter:
Advisory Board
,
Consultancy
,
Honoraria
,
Research Funding
and
Royalty
Amgen, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Riemser, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Neovi, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Medac, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Amgen, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Riemser, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Neovi, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Medac, Advisor, Presenter: Advisory Board , Consultancy , Honoraria , Research Funding and Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Autolus, Advisor:
Advisory Board
Elsalys, Advisor: Consultancy
Eusapharma, Advisor: Consultancy
Novartis, Advisor: Company Driven Protocol
Elsalys, Advisor: Consultancy
Eusapharma, Advisor: Consultancy
Novartis, Advisor: Company Driven Protocol
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, Employment:
Financial Benefit and/or patents
,
Intellectual Property Rights
,
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte Research Institute, Director, Clinical Pharmacokinetics:
Salary
and
Stock
Nothing to Disclose
Angiocrine Bioscience, other:
Research Funding
Nohla Therapeutics, other: Clinical trial regulatory oversight
Nohla Therapeutics, Consultant: Consultancy
Gamida Cell Ltd, other: Research Funding
Gamida Cell Ltd, Consultant: Consultancy
Magenta Therapeutics Inc, Other: Review Panel
Nohla Therapeutics, other: research support
Nohla Therapeutics, other: Clinical trial regulatory oversight
Nohla Therapeutics, Consultant: Consultancy
Gamida Cell Ltd, other: Research Funding
Gamida Cell Ltd, Consultant: Consultancy
Magenta Therapeutics Inc, Other: Review Panel
Nohla Therapeutics, other: research support
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Advisor:
Research Funding
Servier, Advisor: Honoraria
Celgene, Advisor: Honoraria
Shire, Advisor: Honoraria and Research Funding
JazzPharma, Advisor: Honoraria and Travel to congress
Servier, Advisor: Honoraria
Celgene, Advisor: Honoraria
Shire, Advisor: Honoraria and Research Funding
JazzPharma, Advisor: Honoraria and Travel to congress
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alexion, Speaker:
Consultancy
and
speaker
Nothing to Disclose
Epizyme, Novartis, Janssen, BMS, Miragen, Mediimmune, research:
Research Funding
Defined Health, GLG, Guidepoint Global, consulting: Consultancy
dava oncology, honoraria: Honoraria
Defined Health, GLG, Guidepoint Global, consulting: Consultancy
dava oncology, honoraria: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
GlycoMimetics, none:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
medac GmbH, Coordinating investigator:
Consultancy
,
Honoraria
and
Travel support
Kiadis Pharma, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen Cilag, MD:
Advisory Board
and
Speakers bureau
Takeda, MD: Advisory Board and Speakers bureau
Amgen, MD: Advisory Board and Speakers bureau
Sanofi, MD: Advisory Board
Celgene, MD: Speakers bureau
Takeda, MD: Advisory Board and Speakers bureau
Amgen, MD: Advisory Board and Speakers bureau
Sanofi, MD: Advisory Board
Celgene, MD: Speakers bureau
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Support:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc, Chief Medical Officer:
Ownership Interest
and
Salary
Nothing to Disclose
MundiPharma, Phosplatin, Research:
Research Funding
Juno, consulting or advisory role: Consultancy
Amgen, honoraria: Honoraria
Juno, consulting or advisory role: Consultancy
Amgen, honoraria: Honoraria
Nothing to Disclose
Nothing to Disclose
AddMedica, speaking and teaching:
Honoraria
BlueBirdBio, consulting: Consultancy
BlueBirdBio, consulting: Consultancy
Nothing to Disclose
Nothing to Disclose
GSK, Husband is Medical Director:
husband works for GSK
and
Salary
Janssen, Husband was Medical Director: husband worked for Janssen until August 2018 and Salary
Epizyme, collaborator: Financial Benefit and/or patents
Janssen, Husband was Medical Director: husband worked for Janssen until August 2018 and Salary
Epizyme, collaborator: Financial Benefit and/or patents
Nothing to Disclose
medac GmbH, Investigator:
travel grants for scientific meetings
Neovii GmbH, none: Consultancy and Honoraria
Miltenyi GmbH, none: Consultancy and Honoraria
Neovii GmbH, none: Consultancy and Honoraria
Miltenyi GmbH, none: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Hospital Israelita Albert Einstein, dentist:
dentist
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Spectrum, Consultant:
Consultancy
Pfizer, Consultant:
Consultancy
CSL Behring, Consultant: Consultancy
Agios, Consultant: Consultancy
Incyte, Research: Research Funding
CSL Behring, Consultant: Consultancy
Agios, Consultant: Consultancy
Incyte, Research: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Advisory Board
United Healthcare, Employment: Advisory Board
Seattle Genetics, NA: Advisory Board
Celgene, NA: Advisory Board
Juno, NA: Advisory Board
CRISPR Therapeutics, NA: Advisory Board
Kite Pharma, NA: Advisory Board and Consultancy
Pharmacyclics, NA: Advisory Board
Juno, Honoraria: Consultancy
Celgene, Honoraria: Consultancy and Speaker
CRISPR, Honoraria: Consultancy
Kite/Gilead, Honoraria: Consultancy and Speaker
Novartis, Honoraria: Consultancy
United Healthcare, Employment: Advisory Board
Seattle Genetics, NA: Advisory Board
Celgene, NA: Advisory Board
Juno, NA: Advisory Board
CRISPR Therapeutics, NA: Advisory Board
Kite Pharma, NA: Advisory Board and Consultancy
Pharmacyclics, NA: Advisory Board
Juno, Honoraria: Consultancy
Celgene, Honoraria: Consultancy and Speaker
CRISPR, Honoraria: Consultancy
Kite/Gilead, Honoraria: Consultancy and Speaker
Novartis, Honoraria: Consultancy
Jazz Pharmaceuticals, Consulting:
Advisory Board
and
Consultancy
Novartis, Consulting: Consultancy
Amgen, Consulting: Consultancy
AbbVie, Consulting: Clinical Trials
Pharmacyclics, Consulting: Clinical Trials
Novartis, Advisor: Advisory Board and Consultancy
Novartis, Consulting: Consultancy
Amgen, Consulting: Consultancy
AbbVie, Consulting: Clinical Trials
Pharmacyclics, Consulting: Clinical Trials
Novartis, Advisor: Advisory Board and Consultancy
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Kariurs, Inc., Investigative Computational Biologist:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi Biotec, Speaker:
Honoraria
Nothing to Disclose
Novartis, Employee:
Salary
Incyte Corporation, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
AbbVie, Honoraria, advisory board membership, research funding:
Advisory Board
,
Honoraria
and
Research Funding
Janssen, Research funding and speaker's bureau: Research Funding and Speaker's bureau
Roche, Honoraria: Honoraria
Janssen, Research funding and speaker's bureau: Research Funding and Speaker's bureau
Roche, Honoraria: Honoraria
Morphosys, NA:
Research Funding
Seattle Genetics, NA: Research Funding
Celgene, NA: Research Funding
Novartis, NA: Research Funding
Seattle Genetics, NA: Research Funding
Celgene, NA: Research Funding
Novartis, NA: Research Funding
Nothing to Disclose
Nothing to Disclose
SANOFI, HONORARIA AND RESEARCH FUNDING:
Honoraria
and
Research Funding
CELGENE, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
BRISTOL-MYERS SQUIBB, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
NOVARTIS, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
AMGEN, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
JANSSEN, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
ABBVIE, HONORARIA: Honoraria
MUNDIPHARMA, RESEARCH FUNDING: Research Funding
CELGENE, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
BRISTOL-MYERS SQUIBB, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
NOVARTIS, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
AMGEN, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
JANSSEN, HONORARIA AND RESEARCH FUNDING: Honoraria and Research Funding
ABBVIE, HONORARIA: Honoraria
MUNDIPHARMA, RESEARCH FUNDING: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Ablynx, Consultant:
Consultancy
Ansun Biopharma, Consultant, Study PI: Consultancy and Research Funding
Artemis, Consultant: Advisory Board and Consultancy
Astellas, Consultant, Study PI: Consultancy and Research Funding
Bavarian Nordic, Consultant: Consultancy
Chimerix, Consultant, Study PI: Consultancy and Research Funding
Gilead, Consultant, Study PI: Consultancy and Research Funding
GSK, Study PI: Research Funding
Janssen, Consultant: Advisory Board and Consultancy
Merck, Consultant, Study PI: Consultancy and Research Funding
Moderna Therapeutics, Consultant: Consultancy
Lophius, Research funding: Research Funding
Ansun Biopharma, Investigator: Consultancy and Research grant
Ansun Biopharma, Consultant, Study PI: Consultancy and Research Funding
Artemis, Consultant: Advisory Board and Consultancy
Astellas, Consultant, Study PI: Consultancy and Research Funding
Bavarian Nordic, Consultant: Consultancy
Chimerix, Consultant, Study PI: Consultancy and Research Funding
Gilead, Consultant, Study PI: Consultancy and Research Funding
GSK, Study PI: Research Funding
Janssen, Consultant: Advisory Board and Consultancy
Merck, Consultant, Study PI: Consultancy and Research Funding
Moderna Therapeutics, Consultant: Consultancy
Lophius, Research funding: Research Funding
Ansun Biopharma, Investigator: Consultancy and Research grant
Magenta, Chair DMC clinical trial:
Consultancy
Chimerix, Chair of DMC clinical trial: Consultancy
bluebird bio, consultant: Consultancy
Chiltern, Chair DSMB for P3 clinical trial Chimerix: Consultancy
Magenta, Chair DSMB P2 clinical trial: Consultancy
Chimerix, Chair of DMC clinical trial: Consultancy
bluebird bio, consultant: Consultancy
Chiltern, Chair DSMB for P3 clinical trial Chimerix: Consultancy
Magenta, Chair DSMB P2 clinical trial: Consultancy
Nothing to Disclose
BioLineRx Ltd, Project Manager:
Ownership Interest
and
Salary
Novartis, Advisor:
Advisory Board
,
Honoraria
and
Research Funding
Magenta Therapeutics, Employment:
Ownership Interest
and
Salary
Magenta Therapeutics, employee: Intellectual Property Rights , Ownership Interest and Salary
Magenta Therapeutics, employee: Intellectual Property Rights , Ownership Interest and Salary
Nothing to Disclose
Nothing to Disclose
Incyte, DSMB member:
Consultancy
Nothing to Disclose
Torque, SAB:
Advisory Board
Neximmune, Scientific Advisory Board: Advisory Board
Cellectis, SAB: Advisory Board
Mana Therapeutics, Co-Founder: Ownership Interest
Neximmune, Scientific Advisory Board: Advisory Board
Cellectis, SAB: Advisory Board
Mana Therapeutics, Co-Founder: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employment:
Salary
Nothing to Disclose
Kiadis Pharma, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Honoraria
Nothing to Disclose
Windmiltherapheutics, consultatnt:
Consultancy
,
Financial Benefit and/or patents
,
Intellectual Property Rights
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead, Employment:
Ownership Interest
and
Salary
Kite, Employment: Ownership Interest
Kite, Employment: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gamida Cell, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Study Staff:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Coord educational programme and workshop:
Honoraria
CBMTG, Past President: On the Executive
Otsuka, consultant re new drugs: Consultancy
Kyte, DSMB member: Consultancy
Merck, market research: Honoraria
Cancer Care Ontario, Lead, Quality and Access for Complex Malignant Hematology: Salary
CBMTG, Past President: On the Executive
Otsuka, consultant re new drugs: Consultancy
Kyte, DSMB member: Consultancy
Merck, market research: Honoraria
Cancer Care Ontario, Lead, Quality and Access for Complex Malignant Hematology: Salary
Nothing to Disclose
Tessa Therapuetics, Advisory Board:
Advisory Board
and
Financial Benefit and/or patents
Viracyte, Co-founder: Advisory Board and Ownership Interest
Marker Therapeutics, Co-founder: Advisory Board and Ownership Interest
Unum Therapuetics, Advisory Board: Advisory Board
Cell Medica, Non: Research Funding
Turnstone Therapeutics, Ad Board: Advisory Board
Torque, Ad Board: Advisory Board
bluebird bio, Ad Board: Advisory Board
Viracyte, Co-founder: Advisory Board and Ownership Interest
Marker Therapeutics, Co-founder: Advisory Board and Ownership Interest
Unum Therapuetics, Advisory Board: Advisory Board
Cell Medica, Non: Research Funding
Turnstone Therapeutics, Ad Board: Advisory Board
Torque, Ad Board: Advisory Board
bluebird bio, Ad Board: Advisory Board
Juno, None:
Advisory Board
,
Consultancy
,
Intellectual Property Rights
and
Research Funding
Celgene: Consultancy
Celgene: Consultancy
Nothing to Disclose
Lyst Therapeutics, Founder:
Intellectual Property Rights
,
Ownership Interest
and
Royalty
Gunze Limited, Investigator: Research Funding
Cook Regentec, Investigator: Research Funding
University of Wisconsin Heart Regenerative Group, Advisor: Advisory Board
Gunze Limited, Investigator: Research Funding
Cook Regentec, Investigator: Research Funding
University of Wisconsin Heart Regenerative Group, Advisor: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cidara Therapeutics, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
GILEAD, Honoraria:
Honoraria
PFIZER, Honoraria: Honoraria
HOSPIRA, Honoraria: Honoraria
CELGENE, Honoraria and research funding: Honoraria and Research Funding
PIERRE FABRE, research funding: Research Funding
ADIENNE, research funding: Research Funding
HOSPIRA ITALIA, research funding: Research Funding
MSD ITALIA, research funding: Research Funding
PFIZER, Honoraria: Honoraria
HOSPIRA, Honoraria: Honoraria
CELGENE, Honoraria and research funding: Honoraria and Research Funding
PIERRE FABRE, research funding: Research Funding
ADIENNE, research funding: Research Funding
HOSPIRA ITALIA, research funding: Research Funding
MSD ITALIA, research funding: Research Funding
Nothing to Disclose
Nothing to Disclose
GamidaCEll, investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Helsinn, Researcher:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Advisor:
Consultancy
,
Honoraria
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
C
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi Biotec, Received research funding:
Research Funding
Celgene, None: Research Funding
Jazz Pharmaceuticals, Consultant: Honoraria
Celgene, None: Research Funding
Jazz Pharmaceuticals, Consultant: Honoraria
Nothing to Disclose
Clinical Trial Services, Inc., Employee:
Salary
Nothing to Disclose
Seattle Genetics, Research funding:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, None:
Advisory Board
Pfizer, None: Advisory Board
Pfizer, None: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Support:
Advisory Board
,
Research Funding
and
speakers bureau, expert testimony
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
medac GmbH, Investigator:
Research Funding
Adaptive Biotechnologies, Consultant:
Consultancy
Merck, Research Funding: Research Funding
Pfizer, Consultant: Consultancy and Research Funding
Amgen, Consultant: Consultancy and Research Funding
Incyte, Research Funding: Research Funding
Kite Pharma, Research Funding: Research Funding
Jazz Pharmaceuticals, Consultant: Consultancy
Seattle Genetics, Not Applicable: Research Funding and Spouse Employment
Merck, Research Funding: Research Funding
Pfizer, Consultant: Consultancy and Research Funding
Amgen, Consultant: Consultancy and Research Funding
Incyte, Research Funding: Research Funding
Kite Pharma, Research Funding: Research Funding
Jazz Pharmaceuticals, Consultant: Consultancy
Seattle Genetics, Not Applicable: Research Funding and Spouse Employment
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer, advisory board member:
Advisory Board
and
Consultancy
Incyte, advisory board member: Advisory Board and Consultancy
Bluebird, Own bio stocks: Ownership Interest
Incyte, advisory board member: Advisory Board and Consultancy
Bluebird, Own bio stocks: Ownership Interest
Nothing to Disclose
Novartis, Speaking:
Honoraria
Sanofi, Speaking, consultant, funding recipient: Consultancy , Honoraria and Research Funding
Gilead, Speaking, consultant: Consultancy and Honoraria
Sanofi, Speaking, consultant, funding recipient: Consultancy , Honoraria and Research Funding
Gilead, Speaking, consultant: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Consulting:
Consultancy
Nothing to Disclose
Chimerix, Consulting:
Consultancy
Analytica Laser, Employment: Salary
Analytica Laser, Employment: Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Investigator:
Research Funding
BMS, Investigator: Research Funding
BMS, Research: Research Funding
Bluebird Bio, Consultant: Consultancy
BMS, Investigator: Research Funding
BMS, Research: Research Funding
Bluebird Bio, Consultant: Consultancy
Nothing to Disclose
Merck, received grant:
Honoraria
and
Research Funding
Chimerix, received grant: Honoraria and Research Funding
AiCuris, received grant: Research Funding
Novartis, received grant: Research Funding
Shire, received grant: Honoraria and Research Funding
Oxford, received grant: Honoraria and Research Funding
Astellas, other: Honoraria
MSD, other: Honoraria
Shire, Consulting and Research: Consultancy and Research Funding
Novartis, Research: Research Funding
Chimerix, Consulting and Research: Consultancy and Research Funding
Oxford Immunotec, Consulting and Research: Consultancy and Research Funding
Merck, Consulting and Research: Consultancy and Research Funding
Astellas, Consulting: Consultancy
Ansun Biopharma, Investigator: Consultancy and Research grant
Merck, Chimerix, Shire, Oxford Immunotec, Astellas, Consultancy: Honoraria
Merck, Chimerix, Shire, Oxford, Immunotec, Novartis, PI: Research Grants
Chimerix, received grant: Honoraria and Research Funding
AiCuris, received grant: Research Funding
Novartis, received grant: Research Funding
Shire, received grant: Honoraria and Research Funding
Oxford, received grant: Honoraria and Research Funding
Astellas, other: Honoraria
MSD, other: Honoraria
Shire, Consulting and Research: Consultancy and Research Funding
Novartis, Research: Research Funding
Chimerix, Consulting and Research: Consultancy and Research Funding
Oxford Immunotec, Consulting and Research: Consultancy and Research Funding
Merck, Consulting and Research: Consultancy and Research Funding
Astellas, Consulting: Consultancy
Ansun Biopharma, Investigator: Consultancy and Research grant
Merck, Chimerix, Shire, Oxford Immunotec, Astellas, Consultancy: Honoraria
Merck, Chimerix, Shire, Oxford, Immunotec, Novartis, PI: Research Grants
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
BioLineRx Ltd, Medical Director:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte Research Institute, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Incyte Corporation, Consultant:
Consultancy
Magenta, Consultant: Consultancy
Takeda, Consultant: Consultancy
Kiadis, Consultant: Consultancy
Magenta, Consultant: Consultancy
Takeda, Consultant: Consultancy
Kiadis, Consultant: Consultancy
bluebird bio, Inc., Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen Biopharma, Inc., Employee:
Financial Benefit and/or patents
and
Salary
bluebird bio, consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, MD:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NeoImmuneTech, PI-Research Funding:
Research Funding
Bigelow Aerospace, Project Leader-Research Funding: Research Funding
Bigelow Aerospace, Project Leader-Research Funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NYSTEM, advisory board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
medac GmbH, Investigator:
travel grants for scientific meetings
Nothing to Disclose
Fate Therapeutics, consultant, contracted research:
Consultancy
,
Intellectual Property Rights
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Kiadis, Speaker, Advisory Board Member:
Advisory Board
and
Honoraria
Miltenyi, None: Research Funding
MolMed, Advisory Board Member: Advisory Board
CytoSen, Founder, Advisory Board Member: Advisory Board and Ownership Interest
Miltenyi, None: Research Funding
MolMed, Advisory Board Member: Advisory Board
CytoSen, Founder, Advisory Board Member: Advisory Board and Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lam Therapeutics, Research Funding:
Research Funding
Takeda, Research Funding: Research Funding
Novartis, Research Funding: Research Funding
BMS, Research Funding: Research Funding
Janssen, Ad board/consulting: Advisory Board and Consultancy
Abbvie, Ad board/consulting: Advisory Board and Consultancy
Seattle Genetics, Ad board/consulting: Advisory Board and Consultancy
Genentech, Ad board/consulting: Advisory Board and Consultancy
Bioinvent, Ad board/consulting: Advisory Board and Consultancy
BioInvent, Research Funding: Research Funding
Takeda, Research Funding: Research Funding
Novartis, Research Funding: Research Funding
BMS, Research Funding: Research Funding
Janssen, Ad board/consulting: Advisory Board and Consultancy
Abbvie, Ad board/consulting: Advisory Board and Consultancy
Seattle Genetics, Ad board/consulting: Advisory Board and Consultancy
Genentech, Ad board/consulting: Advisory Board and Consultancy
Bioinvent, Ad board/consulting: Advisory Board and Consultancy
BioInvent, Research Funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Amgen Inc., Health Economics Director:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz pharmaceuticals, consultant:
Advisory Board
Jazz pharmaceuticals, speaker: Honoraria
Jazz pharmaceuticals, med education consultant: Consultancy
Jazz pharmaceuticals, investigator: Research Funding
Jazz pharmaceuticals, consultant: Advisory Board , Consultancy , Honoraria , Research Funding and Speaker
Jazz pharmaceuticals, Consultant: Advisory Board , Consultancy , Honoraria , Research Funding and Speaker
Jazz Pharmaceuticals, Speaker: Honoraria
Jazz Pharmaceuticals, Advisory Board: Honoraria
Jazz Pharmaceuticals, Laboratory Research: Research Grant
Jazz pharmaceuticals, speaker: Honoraria
Jazz pharmaceuticals, med education consultant: Consultancy
Jazz pharmaceuticals, investigator: Research Funding
Jazz pharmaceuticals, consultant: Advisory Board , Consultancy , Honoraria , Research Funding and Speaker
Jazz pharmaceuticals, Consultant: Advisory Board , Consultancy , Honoraria , Research Funding and Speaker
Jazz Pharmaceuticals, Speaker: Honoraria
Jazz Pharmaceuticals, Advisory Board: Honoraria
Jazz Pharmaceuticals, Laboratory Research: Research Grant
Magenta Therapeutics, Management Position:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
WUGEN, Consultant:
Consultancy
WUGEN, Consultant: Consultancy , Intellectual Property Rights and Ownership Interest
WUGEN, Consultant: Consultancy and Ownership Interest
WUGEN, Consultant: Consultancy , Intellectual Property Rights and Ownership Interest
WUGEN, Consultant: Consultancy and Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gentium/Jazz Pharmaceuticals, Support:
Consultancy
and
Honoraria
Viracor Eurofins, Coordinator:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Hospital Israelita Albert Einstein, dentist:
dentist
Nothing to Disclose
Pfizer, Consultant:
Consultancy
and
Research Funding
Daiichi Sankyo, Consultant: Consultancy and Research Funding
Novartis, Consultant: Consultancy and Research Funding
Astellas Pharma, Consultant: Consultancy and Research Funding
Arog, Research: Research Funding
Daiichi Sankyo, Consultant: Consultancy and Research Funding
Novartis, Consultant: Consultancy and Research Funding
Astellas Pharma, Consultant: Consultancy and Research Funding
Arog, Research: Research Funding
Merck and Co, Inc, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, consultant:
Honoraria
AbbVie, consultant: Honoraria
Amgen, consultant: Honoraria
Celgene, consultant: Honoraria
Celgene, investigator: Research Funding
AbbVie, investigator: Research Funding
Janssen, investigator: Research Funding
Amgen, investigator: Research Funding
Sanofi, consultant: Speaker Fees
Amgen, consultant: Speaker Fees
AbbVie, consultant: Honoraria
Amgen, consultant: Honoraria
Celgene, consultant: Honoraria
Celgene, investigator: Research Funding
AbbVie, investigator: Research Funding
Janssen, investigator: Research Funding
Amgen, investigator: Research Funding
Sanofi, consultant: Speaker Fees
Amgen, consultant: Speaker Fees
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen, investigator:
Research Funding
Juno/Celgene, Investigator: Research Funding
Abbvie, investigator: Research Funding
Sanofi, investigator: Research Funding
Juno/Celgene, Investigator: Research Funding
Abbvie, investigator: Research Funding
Sanofi, investigator: Research Funding
Nothing to Disclose
Bologna Dermatology textbook, Editor:
Royalty
UpToDate, Writer: Royalty
UpToDate, Writer: Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Speakers Bureau:
Advisory Board
and
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Juno Therapeutics:
Consultancy
and
Research Funding
Novartis: Consultancy
Novartis: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cidara Therapeutics, Independent Contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
D
Nothing to Disclose
Hospital Israelita Albert Einstein, data manager:
data manager
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant and part-time employee:
Consultancy
,
Research Funding
and
Salary
Shire, Investigator:
Research Funding
Oxford Immunotec, Investigator: Research Funding
GSK, Investigator: Research Funding
Gilead, Investigator: Research Funding
Ansun Biopharma, Investigator: Research Funding
Merck, Consulting: Advisory Board , Consultancy , Honoraria , Research Funding and Speaker bureau
AiCuris, Investigator: Research Funding
Chimerix, Investigator: Research Funding
Clinigen, Consulting: Advisory Board and Honoraria
Ansun Biopharma, Investigator: Research grant
Oxford Immunotec, Investigator: Research Funding
GSK, Investigator: Research Funding
Gilead, Investigator: Research Funding
Ansun Biopharma, Investigator: Research Funding
Merck, Consulting: Advisory Board , Consultancy , Honoraria , Research Funding and Speaker bureau
AiCuris, Investigator: Research Funding
Chimerix, Investigator: Research Funding
Clinigen, Consulting: Advisory Board and Honoraria
Ansun Biopharma, Investigator: Research grant
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Karius Inc., Medical Director:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead Sciences, NA:
Consultancy
and
Research Funding
Takeda Oncology, NA: Research Funding
Aptose Biosciences, NA: Research Funding
Genentech, NA: Consultancy and Research Funding
Astra Zeneca, NA: Consultancy
Verastem, NA: Consultancy and Research Funding
TG Therapeutics, NA: Consultancy
Bayer Oncology, NA: Consultancy and Research Funding
Takeda Oncology, NA: Research Funding
Aptose Biosciences, NA: Research Funding
Genentech, NA: Consultancy and Research Funding
Astra Zeneca, NA: Consultancy
Verastem, NA: Consultancy and Research Funding
TG Therapeutics, NA: Consultancy
Bayer Oncology, NA: Consultancy and Research Funding
Nothing to Disclose
Nothing to Disclose
Merck, None:
Consultancy
and
Research Funding
Astellas, None: Research Funding
Shire, None: Research Funding
Viracor, None: Research Funding
Astellas, None: Research Funding
Shire, None: Research Funding
Viracor, None: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Ph.D:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, Consultant:
Consultancy
Novartis, Consultant: Consultancy
Celyad, Consultant: Consultancy
CBMG, Consultant: Consultancy
Precision Biosciences, Consultant: Consultancy
Celgene, None: Research Funding
Atara Biotherapeutics, Consultant: Research Funding
Novartis, Consultant: Consultancy
Celyad, Consultant: Consultancy
CBMG, Consultant: Consultancy
Precision Biosciences, Consultant: Consultancy
Celgene, None: Research Funding
Atara Biotherapeutics, Consultant: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
Incyte Corporation, Employee, executive director, oncology drug development:
Salary
Nothing to Disclose
Hospital Israelita Albert Einstein, dentist:
dentist
Nothing to Disclose
AIMM Therapeutics, Graduate student:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, none:
Research Funding
PHarmacyclics, none: Consultancy
Pfizer, none: Consultancy
PHarmacyclics, none: Consultancy
Pfizer, none: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, Inc., employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, Employment:
Financial Benefit and/or patents
,
Intellectual Property Rights
,
Ownership Interest
and
Salary
Nothing to Disclose
Mallinckrodt, funded by organization:
Consultancy
and
Research Funding
Agios, consulting:
Advisory Board
and
Consultancy
BMS, independent contractor: Research Funding
Novartis, Consultancy: Consultancy
BMS, independent contractor: Research Funding
Novartis, Consultancy: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kiadis Pharma, Advisor:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
amgen, advisory board:
Consultancy
kite, advisory board: Consultancy
lava therapeutics, advisory board: Consultancy
kite, advisory board: Consultancy
lava therapeutics, advisory board: Consultancy
Nothing to Disclose
Nothing to Disclose
Helocyte, intellectual property right:
Advisory Board
,
Research Funding
and
Royalty
Pfizer, pharmaceutical manufacturer: provided adjuvant PF03512676 at no cost
Pfizer, pharmaceutical manufacturer: provided adjuvant PF03512676 at no cost
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Sr. Director, Translational Sciences:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Celgene, MD:
Advisory Board
,
Consultancy
and
Honoraria
AMGEN, MD: Advisory Board , Consultancy and Honoraria
Takeda, MD: Advisory Board , Consultancy and Honoraria
Janssen, MD: Advisory Board , Consultancy and Honoraria
BMS, MD: Advisory Board , Consultancy and Honoraria
AMGEN, MD: Advisory Board , Consultancy and Honoraria
Takeda, MD: Advisory Board , Consultancy and Honoraria
Janssen, MD: Advisory Board , Consultancy and Honoraria
BMS, MD: Advisory Board , Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Alexion Pharmaceuticals, Inc., Millenium Taked, Nil:
Participates in the International PNH Registry (for Mayo Clinic, Rochester) for Alexion Pharmaceuticals, Inc.
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Rivervest, Consultant:
Advisory Board
and
Honoraria
California Institute for Regenerative Medicine (CIRM), Grant Review: Honoraria
Hemedicus, Grant Review: Honoraria
Cellworks, Consultant: Advisory Board and Honoraria
Amphivena, Consultant: Advisory Board and Honoraria
Celgene, Speaker: Advisory Board and Honoraria
Bioline, Consultant: Consultancy and Honoraria
Tioma Therapeutics, Collaboration: Advisory Board and Honoraria
Magenta, Founder: Ownership Interest
DAVA Oncology, Speaker: Honoraria
Magenta Therapeutics, Equity Ownership: Ownership Interest
WUGEN, Equity Ownership: Ownership Interest
Amphivena, Consultant: Consultancy and Research Funding
Celgene, Consultant: Consultancy
Incyte, Consultant: Consultancy
Karyopharm Therapeutics, Consultant: Consultancy
RiverVest Venture Partners, Consultanty, Board Member: Advisory Board and Consultancy
Tioma Therpaeutics, Consultanty: Consultancy
Cellworks Group, Inc, Board Member: Advisory Board
Novimmune, Research: Research Funding
Incyte, Honoraria: Honoraria
Magenta Therapeutics, Equity ownership: Ownership Interest
WUGEN, Equity ownership: Ownership Interest
Amphivena Therapeutics, Consultant: Consultancy
RiverVest Venture Partners, Consultant: Consultancy
Tioma Therapeutics (formerly Vasculox, Inc.), Consultant: Consultancy
Cellworks Group, Inc, Membership on a Board or Advisory Committee: Advisory Board
RiverVest Venture Partners, Membership on a Board or Advisory Committee: Advisory Board
Amphivena therapeutics, Recipient of research funding: Research Funding
Novimmune, Recipient of research funding: Research Funding
California Institute for Regenerative Medicine (CIRM), Grant Review: Honoraria
Hemedicus, Grant Review: Honoraria
Cellworks, Consultant: Advisory Board and Honoraria
Amphivena, Consultant: Advisory Board and Honoraria
Celgene, Speaker: Advisory Board and Honoraria
Bioline, Consultant: Consultancy and Honoraria
Tioma Therapeutics, Collaboration: Advisory Board and Honoraria
Magenta, Founder: Ownership Interest
DAVA Oncology, Speaker: Honoraria
Magenta Therapeutics, Equity Ownership: Ownership Interest
WUGEN, Equity Ownership: Ownership Interest
Amphivena, Consultant: Consultancy and Research Funding
Celgene, Consultant: Consultancy
Incyte, Consultant: Consultancy
Karyopharm Therapeutics, Consultant: Consultancy
RiverVest Venture Partners, Consultanty, Board Member: Advisory Board and Consultancy
Tioma Therpaeutics, Consultanty: Consultancy
Cellworks Group, Inc, Board Member: Advisory Board
Novimmune, Research: Research Funding
Incyte, Honoraria: Honoraria
Magenta Therapeutics, Equity ownership: Ownership Interest
WUGEN, Equity ownership: Ownership Interest
Amphivena Therapeutics, Consultant: Consultancy
RiverVest Venture Partners, Consultant: Consultancy
Tioma Therapeutics (formerly Vasculox, Inc.), Consultant: Consultancy
Cellworks Group, Inc, Membership on a Board or Advisory Committee: Advisory Board
RiverVest Venture Partners, Membership on a Board or Advisory Committee: Advisory Board
Amphivena therapeutics, Recipient of research funding: Research Funding
Novimmune, Recipient of research funding: Research Funding
Celgene, Takeda, Prothena, Jannsen, Pfizer, Alnylam, GSK, Nil:
Research Funding
Lophius Biosciences, independent contractor:
Research Funding
Seattle Genetics, advisory board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Achillion Pharmaceuticals, consultant:
Consultancy
Alexion Pharmaceuticals, consultant: Consultancy
Alexion Pharmaceuticals, consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen Inc., Consultant:
Consultancy
,
Honoraria
and
Travel
Roche/Genentech, Advisor/speaker: Advisory Board and Honoraria
Pfizer, Advisor: Advisory Board , Honoraria and Speakers bureau, travel
Ariad (Incyte), Advisor: Advisory Board , Honoraria , Research Funding and Speakers bureau, travel
Jazz Pharma, Advisor: Advisory Board , Honoraria and Research Funding
Kite Pharma, Advisor: Advisory Board , Honoraria and Research Funding
Novartis, Advisor: Advisory Board and Honoraria
Agios, Advisor: Financial Benefit and/or patents and Honoraria
Sunesis, Advisor: Advisory Board and Honoraria
Ambit (Daiichi Sankyo), Advisor: Advisory Board and Honoraria
Karyopharm, Advisor: Advisory Board and Honoraria
Menarini, Advisor: Advisory Board and Honoraria
Astellas, Advisor: Advisory Board and Honoraria
Janssen, Advisor: Advisory Board and Honoraria
Servier, Advisor: Advisory Board and Honoraria
Seattle Genetics, Advisor: Advisory Board and Honoraria
Cellectis, Advisor: Advisory Board and Honoraria
Celgene, Advisor: Advisory Board , Consultancy , Honoraria and Speakers bureau
Roche/Genentech, Advisor/speaker: Advisory Board and Honoraria
Pfizer, Advisor: Advisory Board , Honoraria and Speakers bureau, travel
Ariad (Incyte), Advisor: Advisory Board , Honoraria , Research Funding and Speakers bureau, travel
Jazz Pharma, Advisor: Advisory Board , Honoraria and Research Funding
Kite Pharma, Advisor: Advisory Board , Honoraria and Research Funding
Novartis, Advisor: Advisory Board and Honoraria
Agios, Advisor: Financial Benefit and/or patents and Honoraria
Sunesis, Advisor: Advisory Board and Honoraria
Ambit (Daiichi Sankyo), Advisor: Advisory Board and Honoraria
Karyopharm, Advisor: Advisory Board and Honoraria
Menarini, Advisor: Advisory Board and Honoraria
Astellas, Advisor: Advisory Board and Honoraria
Janssen, Advisor: Advisory Board and Honoraria
Servier, Advisor: Advisory Board and Honoraria
Seattle Genetics, Advisor: Advisory Board and Honoraria
Cellectis, Advisor: Advisory Board and Honoraria
Celgene, Advisor: Advisory Board , Consultancy , Honoraria and Speakers bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Atara Biotherapeutics, Investigator, Consultant:
Consultancy
,
Research Funding
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
medac, Advisory board:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lentigen Technology Inc., Employee:
Financial Benefit and/or patents
,
Intellectual Property Rights
,
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Optum, Inc, Research:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck and Co, Inc, Collaborator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer, None:
Advisory Board
Advanced Clinical, Consultant: Consultancy
Magenta Therapeutics, Consultant: Consultancy
bluebird bio, None: Advisory Board and Consultancy
bluebird bio, Consultant: Consultancy
Advanced Clinical, Consultant: Consultancy
Magenta Therapeutics, Consultant: Consultancy
bluebird bio, None: Advisory Board and Consultancy
bluebird bio, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Humanigen, Chairman and Chief Executive Officer:
Chairman and Chief Executive Officer
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Jazz Pharmaceuticals, Consultant:
Consultancy
Chimerix Inc, Advisor: Advisory Board
Chimerix Inc, Advisor: Advisory Board and Research Funding
Chimerix, Inc, Advisor: Advisory Board
Alexion, Inc, Consultant: Consultancy
Chimerix Inc, Advisor: Advisory Board
Chimerix Inc, Advisor: Advisory Board and Research Funding
Chimerix, Inc, Advisor: Advisory Board
Alexion, Inc, Consultant: Consultancy
E
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Hospital Israelita Albert Einstein, dentist:
dentist
Nothing to Disclose
Celgene, None:
Research Funding
Janssen, None: Speaker's bureau
Takeda, None: Indep Review Committee, Speaker's Bureau
Akcea, None: Speaker's bureau
Janssen, None: Speaker's bureau
Takeda, None: Indep Review Committee, Speaker's Bureau
Akcea, None: Speaker's bureau
Nothing to Disclose
Medtronic, Stock Owner:
Ownership Interest
Vical, Stock Owner: Ownership Interest
Vical, Stock Owner: Ownership Interest
Nothing to Disclose
Nothing to Disclose
bluebird bio, NA:
Research Funding
Nothing to Disclose
Janssen, consultant:
Advisory Board
,
Consultancy
,
Honoraria
and
Research Funding
Celgene, consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Amgen, consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Brisol Myers Squibb, consultant: Advisory Board , Consultancy and Honoraria
Novartis, consultant: Advisory Board , Consultancy and Honoraria
Takeda, consultant: Advisory Board , Consultancy and Honoraria
Celgene, consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Amgen, consultant: Advisory Board , Consultancy , Honoraria and Research Funding
Brisol Myers Squibb, consultant: Advisory Board , Consultancy and Honoraria
Novartis, consultant: Advisory Board , Consultancy and Honoraria
Takeda, consultant: Advisory Board , Consultancy and Honoraria
Kadmon Corporation, LLC, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Investigator:
Travel funding
Nothing to Disclose
Nothing to Disclose
bluebird bio, Inc., employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite a Gilead Company, None:
Honoraria
and
Participation in administrative advisory meeting regarding CAR-T operational processes at hospitals
Juno Therapeutics, None: Honoraria and Participation in administrative advisory meeting regarding CAR-T operational processes at hospitals
Juno Therapeutics, None: Honoraria and Participation in administrative advisory meeting regarding CAR-T operational processes at hospitals
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead Sciences, Inc., Consultant, study PI:
Consultancy
and
Research Funding
Novavax, study PI: Research Funding
GlaxoSmithKline, study PI: Research Funding
Janssen, study PI: Research Funding
MedImmune, study PI: Research Funding
Novavax, study PI: Research Funding
GlaxoSmithKline, study PI: Research Funding
Janssen, study PI: Research Funding
MedImmune, study PI: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Principal Scientist:
Financial Benefit and/or patents
and
Salary
Jazz Pharmaceticals, Speaker:
Honoraria
Incyte, Advisory Board: Advisory Board
Incyte, Advisory Board: Advisory Board
Nothing to Disclose
F
Nothing to Disclose
Jazz Pharmaceuticals, Employment and Equity Ownership:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene:
Speaker's Bureau
Takeda: Speaker's Bureau
Takeda: Speaker's Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, independent contractor:
Honoraria
Kite, speaking and teaching: Travel/Accomodations/Expenses
Kite, speaking and teaching: Travel/Accomodations/Expenses
Nothing to Disclose
Roy Chemaly, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Cure2Children Foundation-Italy (NGO), Medical Director:
Advisory Board
and
Salary
Viracor Eurofins, Supervisor:
Salary
Nothing to Disclose
Jazz, Consultant:
Advisory Board
,
Consultancy
and
Honoraria
Novartis, Consultant: Advisory Board , Consultancy and Honoraria
BMS, Consultant: Advisory Board , Consultancy and Honoraria
Gilead, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
Incyte, Consultant: Advisory Board , Consultancy and Honoraria
Jannsen, Consultant: Advisory Board , Consultancy and Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
Nwartis, Consultant: Advisory Board , Consultancy and Honoraria
Novartis, Consultant: Advisory Board , Consultancy and Honoraria
BMS, Consultant: Advisory Board , Consultancy and Honoraria
Gilead, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
Incyte, Consultant: Advisory Board , Consultancy and Honoraria
Jannsen, Consultant: Advisory Board , Consultancy and Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
Nwartis, Consultant: Advisory Board , Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
CytoSen, SAB Member:
Advisory Board
and
Ownership Interest
Altor BioScience, NA: Research Funding
Celgene, NA: Research Funding
Affimed, NA: Research Funding
Altor BioScience, NA: Research Funding
Celgene, NA: Research Funding
Affimed, NA: Research Funding
Nothing to Disclose
Nothing to Disclose
Sanofi, Speaker:
Honoraria
and
speaker
Astrazeneca, Speaker: Honoraria and speaker
Celgene, Speaker: Honoraria and speaker
Adaptive Biotechnologies, Speaker: Honoraria and speaker
Genentech, Consultant: Consultancy and Honoraria
Astrazeneca, Speaker: Honoraria and speaker
Celgene, Speaker: Honoraria and speaker
Adaptive Biotechnologies, Speaker: Honoraria and speaker
Genentech, Consultant: Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Pfizer, Honoraria:
Honoraria
Sanofi, Honoraria: Speakers Bureau
Sanofi, Honoraria: Speakers Bureau
Nothing to Disclose
Nothing to Disclose
Viracor, Consultant/Advisor:
Consultancy
and
Intellectual Property Rights
Xenikos, Consultant: Consultancy
Xenikos, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Hospital Israelita Albert Einstein, dentist:
dentist
Nothing to Disclose
Nothing to Disclose
Incyte, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Neovii GmbH, Investigator:
Honoraria
,
Research Funding
and
travel grants
Riemser GmbH, Investigator: Honoraria , Research Funding and travel grants
Novartis GmbH, Investigator: Honoraria , Research Funding and travel grants
medac GmbH, Investigator: Honoraria , Research Funding and travel grants
Riemser GmbH, Investigator: Honoraria , Research Funding and travel grants
Novartis GmbH, Investigator: Honoraria , Research Funding and travel grants
medac GmbH, Investigator: Honoraria , Research Funding and travel grants
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Karius, Research Support:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cidara Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Participation in advisory board:
Consultancy
Celgene, Participation in advisory board: Consultancy
Gilead, Participation in advisory board: Consultancy
Janssen, Participation in advisory board: Consultancy
Lundbeck, Participation in advisory board: Consultancy
Merck, Participation in advisory board: Consultancy
Seattle Genetics, Participation in advisory board: Consultancy
Roche, Participation in advisory board: Consultancy
Celgene, Participation in advisory board: Consultancy
Gilead, Participation in advisory board: Consultancy
Janssen, Participation in advisory board: Consultancy
Lundbeck, Participation in advisory board: Consultancy
Merck, Participation in advisory board: Consultancy
Seattle Genetics, Participation in advisory board: Consultancy
Roche, Participation in advisory board: Consultancy
Takeda, independent contractor:
Research Funding
Seattle Genetics, independent contractor: Research Funding
Portola, independent contractor: Research Funding
Pharmacyclics, independent contractor: Research Funding
Pfizer, independent contractor: Research Funding
Novartis, independent contractor: Research Funding
Merck, independent contractor: Research Funding
Kite, independent contractor: Research Funding
Janssen, independent contractor: Research Funding
Infinity, independent contractor: Research Funding
TG Therapuetics, independent contractor: Research Funding
Trillium, independent contractor: Research Funding
Verastem, consulting: Consultancy and Research Funding
Seattle Genetics, independent contractor: Research Funding
Portola, independent contractor: Research Funding
Pharmacyclics, independent contractor: Research Funding
Pfizer, independent contractor: Research Funding
Novartis, independent contractor: Research Funding
Merck, independent contractor: Research Funding
Kite, independent contractor: Research Funding
Janssen, independent contractor: Research Funding
Infinity, independent contractor: Research Funding
TG Therapuetics, independent contractor: Research Funding
Trillium, independent contractor: Research Funding
Verastem, consulting: Consultancy and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Abbvie, NA:
Consultancy
and
Research Funding
Bayer, NA: Consultancy
Denovo Biopharma, NA: Consultancy
Genentech/Roche, NA: Consultancy and Research Funding
Gilead, NA: Consultancy and Research Funding
Karyopharm, NA: Consultancy
Pharmacyclics/Janssen, NA: Consultancy and Research Funding
Spectrum, NA: Consultancy
Acerta, NA: Research Funding
BeiGene, NA: Research Funding
Celgene, NA: Research Funding
TG Therapeutics, NA: Research Funding
OptumRx, NA: Consultancy
Millennium/Takeda, NA: Research Funding
Burroughs Wellcome Fund, NA: Research Funding
Eastern Cooperative Oncology Group, NA: Research Funding
National Cancer Institute, NA: Research Funding
V Foundation, NA: Research Funding
Bayer, NA: Consultancy
Denovo Biopharma, NA: Consultancy
Genentech/Roche, NA: Consultancy and Research Funding
Gilead, NA: Consultancy and Research Funding
Karyopharm, NA: Consultancy
Pharmacyclics/Janssen, NA: Consultancy and Research Funding
Spectrum, NA: Consultancy
Acerta, NA: Research Funding
BeiGene, NA: Research Funding
Celgene, NA: Research Funding
TG Therapeutics, NA: Research Funding
OptumRx, NA: Consultancy
Millennium/Takeda, NA: Research Funding
Burroughs Wellcome Fund, NA: Research Funding
Eastern Cooperative Oncology Group, NA: Research Funding
National Cancer Institute, NA: Research Funding
V Foundation, NA: Research Funding
Pharmacyclics LLC, Consultant:
Honoraria
Pharmacyclics LLC, Investigator: Research Funding
Incyte, Investigator: Research Funding
Astellas, Speaker: Honoraria
Mallinckrodt, Speaker: Honoraria
Pharmacyclics LLC, Investigator: Research Funding
Incyte, Investigator: Research Funding
Astellas, Speaker: Honoraria
Mallinckrodt, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Consultancy
Celgene, Advisor:
Advisory Board
and
Honoraria
Novartis, Advisor: Advisory Board and Honoraria
Janssen, Advisor: Advisory Board and Honoraria
Novartis, Advisor: Advisory Board and Honoraria
Janssen, Advisor: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Cylene, onyx, Celgene, research:
Research Funding
celgene, BMS, Lilly, Binding site, Millenium, Bayer, Novartis, Amgen, Janssen, honoraria: Honoraria
patent for the prognostication of MM based on genetic categorization of the disease, patent owner: Intellectual Property Rights
celgene, lilly, BMS, Binding site, millennium, bayer, Novartis, Amgen, Adaptive Biotechnologies, Janssen, AbvieVie, advisory role: Consultancy
celgene, BMS, Lilly, Binding site, Millenium, Bayer, Novartis, Amgen, Janssen, honoraria: Honoraria
patent for the prognostication of MM based on genetic categorization of the disease, patent owner: Intellectual Property Rights
celgene, lilly, BMS, Binding site, millennium, bayer, Novartis, Amgen, Adaptive Biotechnologies, Janssen, AbvieVie, advisory role: Consultancy
Clinigen, Advisory board:
Advisory Board
Alk-Abello, Speaker: speaker
Alk-Abello, Speaker: speaker
Trillium:
Research Funding
Merck: Research Funding
Merck: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Mustang Biotech, Consultant:
Intellectual Property Rights
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Tolero Pharmaceuticals, Inc., Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceutical, Speaker:
Honoraria
CRISP Therapeutics, Advisory Board Member: Advisory Board
Vertex Therapeutics, Advisory Board Member: Advisory Board
CRISP Therapeutics, Advisory Board Member: Advisory Board
Vertex Therapeutics, Advisory Board Member: Advisory Board
Amgen Inc., Medical Director:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, None:
Research Funding
Pfizer, None: Research Funding
GlaxoSmithKline, None: Research Funding
Pfizer, None: Research Funding
GlaxoSmithKline, None: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Astellas Pharma, Speaker Bureau Member:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
G
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Magenta Therapeutics, employee: Salary
Magenta Therapeutics, employee: Salary
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene corp., Executive Director of Clinical Research:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
CellSight Inc, founder and equity holder:
Ownership Interest
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, Speaker's Bureau:
Honoraria
Amgen, Consultant: Advisory Board
Takeda, Consultant: Consultancy
Janssen, Ad Board: Advisory Board and Research Funding
Diichi Sankyo, Research: Research Funding and Travel assistance
Kite Pharma, Ad Board: Advisory Board
Amgen, Consultant: Advisory Board
Takeda, Consultant: Consultancy
Janssen, Ad Board: Advisory Board and Research Funding
Diichi Sankyo, Research: Research Funding and Travel assistance
Kite Pharma, Ad Board: Advisory Board
Nothing to Disclose
Nothing to Disclose
Pharmerit International, Asia-Pacific Regional Lead, Partner and Excecutive director:
Consultancy
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Speakers Bureau:
Consultancy
Nothing to Disclose
Nothing to Disclose
Amgen, MD:
Honoraria
Celgene, MD: Advisory Board and Honoraria
Takeda, MD: Advisory Board and Honoraria
Seattle Genetics, MD: Advisory Board
Roche, MD: Advisory Board
Janssen, MD: Honoraria
BMS, MD: Honoraria
Celgene, MD: Advisory Board and Honoraria
Takeda, MD: Advisory Board and Honoraria
Seattle Genetics, MD: Advisory Board
Roche, MD: Advisory Board
Janssen, MD: Honoraria
BMS, MD: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
Nothing to Disclose
Nothing to Disclose
Tesaro, Speaker Bureau:
Speaker Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., Senior Scientific and Business Associate:
Ownership Interest
and
Salary
Nothing to Disclose
Scisco Genetics, Inc, Research director:
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, Consultant:
Consultancy
CTI Biopharma, Consultant: Consultancy
Apexx Oncology, Consultant: Consultancy
Celgene, Consultant: Consultancy
CTI Biopharma, Consultant: Consultancy
Apexx Oncology, Consultant: Consultancy
Celgene, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Ionis, alnylam, prothena, nil:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Dava Oncology, None:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead, Speaker:
Speaker Bureau
Abbvie, Speaker: Speaker Bureau
PCYC, Speaker: Consultancy and Speaker Bureau
SGN, Speaker: Speaker Bureau
Juno, Consultant: Consultancy
KITE, Consultant: Consultancy
BMS, Consultant: Consultancy
Abbvie, Speaker: Speaker Bureau
PCYC, Speaker: Consultancy and Speaker Bureau
SGN, Speaker: Speaker Bureau
Juno, Consultant: Consultancy
KITE, Consultant: Consultancy
BMS, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi Pasteur, Independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AMGEN, Consultant:
Advisory Board
and
Research Funding
Actinuum, Consultant: Advisory Board and Research Funding
Celgene, Consultant: Advisory Board and Research Funding
Johnson & Johnson, Consultant: Advisory Board and Research Funding
JAZZ pharmaceutical, Consultant: Advisory Board
MILTENYI, Consultant: Research Funding
TAKEDA, Consultant: Advisory Board and Research Funding
NOVARTIS, Consultant: Advisory Board
KITE, Consultant: Advisory Board
SPECTRUM Pharma, Consultant: Advisory Board
Pfizer, Member: Honoraria
CSL Behring, Member: Honoraria
Gilead, Member: Honoraria
Johnson and Johnson, Member: Honoraria and Research Funding
Novartis, Member: Honoraria
Takeda, Member: Honoraria and Research Funding
Mitenyi, Member: Honoraria and Research Funding
Amgen, Member: Honoraria and Research Funding
Sanofi, Member: Honoraria and Research Funding
Celgene, Member: Honoraria and Research Funding
Actinuum, Member: Honoraria and Research Funding
Jazz Pharmaceuticals, Novartis, Kite, Spectrum Pharma, Consultant: Stipend
Miltenyi, Researcher: Stipend
Actinium, Celgene, Johnson & Johnson, Takeda, Amgen, Consultant/Researcher: Stipend
Actinuum, Consultant: Advisory Board and Research Funding
Celgene, Consultant: Advisory Board and Research Funding
Johnson & Johnson, Consultant: Advisory Board and Research Funding
JAZZ pharmaceutical, Consultant: Advisory Board
MILTENYI, Consultant: Research Funding
TAKEDA, Consultant: Advisory Board and Research Funding
NOVARTIS, Consultant: Advisory Board
KITE, Consultant: Advisory Board
SPECTRUM Pharma, Consultant: Advisory Board
Pfizer, Member: Honoraria
CSL Behring, Member: Honoraria
Gilead, Member: Honoraria
Johnson and Johnson, Member: Honoraria and Research Funding
Novartis, Member: Honoraria
Takeda, Member: Honoraria and Research Funding
Mitenyi, Member: Honoraria and Research Funding
Amgen, Member: Honoraria and Research Funding
Sanofi, Member: Honoraria and Research Funding
Celgene, Member: Honoraria and Research Funding
Actinuum, Member: Honoraria and Research Funding
Jazz Pharmaceuticals, Novartis, Kite, Spectrum Pharma, Consultant: Stipend
Miltenyi, Researcher: Stipend
Actinium, Celgene, Johnson & Johnson, Takeda, Amgen, Consultant/Researcher: Stipend
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pfizer Inc, Other:
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Kite, Employment:
Salary
Hospital Israelita Albert Einstein, dentist:
dentist
Nothing to Disclose
UpToDate, Inc., article author:
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, MD:
Advisory Board
and
Research Funding
BMS, MD: Research Funding
Celgene, MD: Advisory Board , Honoraria and Research Funding
Chugai, MD: Honoraria and Research Funding
Janssen, MD: Advisory Board , Honoraria and Research Funding
Sanofi, MD: Advisory Board and Research Funding
Mundipharma, MD: Research Funding
Takeda, MD: Advisory Board and Research Funding
Novartis, MD: Honoraria and Research Funding
Adaptive Biotechnology, MD: Advisory Board
ArtTempi, MD: Honoraria
BMS, MD: Research Funding
Celgene, MD: Advisory Board , Honoraria and Research Funding
Chugai, MD: Honoraria and Research Funding
Janssen, MD: Advisory Board , Honoraria and Research Funding
Sanofi, MD: Advisory Board and Research Funding
Mundipharma, MD: Research Funding
Takeda, MD: Advisory Board and Research Funding
Novartis, MD: Honoraria and Research Funding
Adaptive Biotechnology, MD: Advisory Board
ArtTempi, MD: Honoraria
Novartis, Advisor:
Honoraria
GLG (Gerson Lehrman Group), Consultant: Consultancy
Stanford Health Care, BMT Business Mgr: Salary
Health Strategies, Consultant: Consultancy
GLG (Gerson Lehrman Group), Consultant: Consultancy
Stanford Health Care, BMT Business Mgr: Salary
Health Strategies, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Consultant:
Advisory Board
and
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, Research Scientist III:
Salary
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kadmon Corporation, LLC, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
medac GmbH, Investigator:
travel grants to scientific meetings
QB Consulting, Owner:
Ownership Interest
Viracyte, Consultant: Consultancy
Lokon, Consultant: Consultancy
Viracyte, Consultant: Consultancy
Lokon, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, advisory board:
Advisory Board
Incyte, Speaker:
Speaker Bureau
Cardinal Health, Spekaer: Speaker Bureau
Pfizer, Speaker: Speaker Bureau
Merck, Speaker: Speaker Bureau
Amgen, Speaker: Speaker Bureau
Celgene, Speaker: Speaker Bureau
Cardinal Health, Spekaer: Speaker Bureau
Pfizer, Speaker: Speaker Bureau
Merck, Speaker: Speaker Bureau
Amgen, Speaker: Speaker Bureau
Celgene, Speaker: Speaker Bureau
Novartis, Consultant, advisory board, research funding:
Advisory Board
,
Consultancy
and
Research Funding
Servier, Consultant, advisory board, research funding: Advisory Board , Consultancy and Research Funding
Kite, Consultant, advisory board, research funding: Advisory Board , Consultancy and Research Funding
Adaptimmune, Consultant, advisory board: Advisory Board and Consultancy
Eureka, Consultant, advisory board: Advisory Board and Consultancy
TCR2, Consultant, advisory board: Advisory Board and Consultancy
Juno, Consultant, advisory board: Advisory Board and Consultancy
GlaskoSmithKline, Consultant, advisory board: Advisory Board and Consultancy
Cellectis, Consultant, advisory board: Advisory Board and Consultancy
Vertex, Consultant, advisory board: Advisory Board and Consultancy
Roche, Consultant, advisory board: Advisory Board and Consultancy
Janssen, Consultant, advisory board: Advisory Board and Consultancy
University of Pennsylvania, Listed on patent: Financial Benefit and/or patents
Servier, Consultant, advisory board, research funding: Advisory Board , Consultancy and Research Funding
Kite, Consultant, advisory board, research funding: Advisory Board , Consultancy and Research Funding
Adaptimmune, Consultant, advisory board: Advisory Board and Consultancy
Eureka, Consultant, advisory board: Advisory Board and Consultancy
TCR2, Consultant, advisory board: Advisory Board and Consultancy
Juno, Consultant, advisory board: Advisory Board and Consultancy
GlaskoSmithKline, Consultant, advisory board: Advisory Board and Consultancy
Cellectis, Consultant, advisory board: Advisory Board and Consultancy
Vertex, Consultant, advisory board: Advisory Board and Consultancy
Roche, Consultant, advisory board: Advisory Board and Consultancy
Janssen, Consultant, advisory board: Advisory Board and Consultancy
University of Pennsylvania, Listed on patent: Financial Benefit and/or patents
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Study Investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celularity, Executive Vice President, Chief Innovation Officer:
Financial Benefit and/or patents
,
Ownership Interest
and
Salary
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, other:
Research Funding
H
NeoImmuneTech, Principle scientist:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, None:
Research Funding
NIH, None: Research Funding
NIH, None: Research Funding
Nothing to Disclose
Nothing to Disclose
Novartis, Employee:
Salary
Takeda, MD:
Consultancy
,
Honoraria
and
Research Funding
BMS, MD: Consultancy and Honoraria
Amgen, MD: Consultancy , Honoraria and Research Funding
Janssen, MD: Consultancy , Honoraria and Research Funding
Celgene, MD: Consultancy and Honoraria
Novartis, MD: Research Funding
BMS, MD: Consultancy and Honoraria
Amgen, MD: Consultancy , Honoraria and Research Funding
Janssen, MD: Consultancy , Honoraria and Research Funding
Celgene, MD: Consultancy and Honoraria
Novartis, MD: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, None:
Research Funding
Otsuka, None: Research Funding
Spectrum, None: Research Funding
Astellas, None: Research Funding
Incyte, None: Advisory Board
Pharmacyclics, none: Advisory Board
Otsuka, None: Research Funding
Spectrum, None: Research Funding
Astellas, None: Research Funding
Incyte, None: Advisory Board
Pharmacyclics, none: Advisory Board
Nothing to Disclose
Nothing to Disclose
Pfizer, education talk:
Honoraria
Nothing to Disclose
Merck, Site Principal Investigator for a clinical trial:
Research Funding
Nothing to Disclose
Ziopharm, Consultant:
Consultancy
Nexus Global Group LLC, Consultant: Consultancy
Merk, Consultant: Consultancy
Nexus Global Group LLC, Consultant: Consultancy
Merk, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Mana Therapeutics, Co-founder:
Ownership Interest
Mana Therapeutics, Co-Founder, Director: Consultancy , Financial Benefit and/or patents , Intellectual Property Rights and Ownership Interest
Mana Therapeutics, Co-Founder, Director: Consultancy , Financial Benefit and/or patents , Intellectual Property Rights and Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Juno, None:
Consultancy
Kite, None: Consultancy
Spectrum, None: Consultancy , Honoraria and Research Funding
Janssen, None: Consultancy , Honoraria and Research Funding
Takeda, None: Consultancy , Honoraria and Research Funding
Celgene, None: Consultancy , Honoraria and Research Funding
BMS, None: Consultancy
Kite, None: Consultancy
Spectrum, None: Consultancy , Honoraria and Research Funding
Janssen, None: Consultancy , Honoraria and Research Funding
Takeda, None: Consultancy , Honoraria and Research Funding
Celgene, None: Consultancy , Honoraria and Research Funding
BMS, None: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
MALLINCKDROT, SPEAKER IN AN EDUCATION MEETING ONLY:
Consultancy
and
Honoraria
Mallinckrodt, Speaker at Education Conference: Honoraria
Mallinckrodt, Speaker at Education Conference: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
DAVA Oncology, Lecturer:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
The Ottawa Hospital, Research Student:
Summer Research Student Pay
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, independent contractor:
Research Funding
Bristol-Meyers Squibb, consulting: Consultancy and Research Funding
Genentech, consulting: Consultancy and Research Funding
Immune Design, independent contractor: Research Funding
Kite, consulting: Consultancy and Research Funding
Merck, consulting: Consultancy and Research Funding
Pharmacyclics, consulting: Consultancy and Research Funding
AstraZeneca, independent contractor: Research Funding
Gilead Sciences, independent contractor: Research Funding
Bristol-Meyers Squibb, consulting: Consultancy and Research Funding
Genentech, consulting: Consultancy and Research Funding
Immune Design, independent contractor: Research Funding
Kite, consulting: Consultancy and Research Funding
Merck, consulting: Consultancy and Research Funding
Pharmacyclics, consulting: Consultancy and Research Funding
AstraZeneca, independent contractor: Research Funding
Gilead Sciences, independent contractor: Research Funding
Nothing to Disclose
Nothing to Disclose
Viracyte, Co-founder:
Advisory Board
and
Ownership Interest
Marker Therapeutics, Co-founder: Advisory Board and Ownership Interest
Gilead, Advisory Board: Advisory Board
Cytosen, Advisory Board: Advisory Board
Cell Medica, None: Intellectual Property Rights and Research Funding
Tessa Therapeutics, None: Research Funding
Marker Therapeutics, Co-founder: Advisory Board and Ownership Interest
Gilead, Advisory Board: Advisory Board
Cytosen, Advisory Board: Advisory Board
Cell Medica, None: Intellectual Property Rights and Research Funding
Tessa Therapeutics, None: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, none:
Advisory Board
Takeda, Investigator: Research Funding
JAZZ, Investigator: Research Funding
Pharmacyclics, Investigator: Research Funding
Axim, none: Ownership Interest
Juno, none: Ownership Interest
Kite, none: Ownership Interest
Novartis, none: Ownership Interest
Insys Therapeutics, none: Ownership Interest
Abbvie, none: Ownership Interest
GW Pharmaceuticals, none: Ownership Interest
Cardinal Health, none: Ownership Interest
Immunomedics, none: Ownership Interest
Endocyte, none: Ownership Interest
Clovis Oncology, none: Ownership Interest
Cellectis, none: Ownership Interest
Aetna, none: Ownership Interest
CVS Health, none: Ownership Interest
Celgene, none: Ownership Interest
Bluebird, none: Ownership Interest
Crisper, none: Ownership Interest
Pfizer, none: Ownership Interest
Idexx Labs, none: Ownership Interest
Vertex, none: Ownership Interest
Takeda, Investigator: Research Funding
JAZZ, Investigator: Research Funding
Pharmacyclics, Investigator: Research Funding
Axim, none: Ownership Interest
Juno, none: Ownership Interest
Kite, none: Ownership Interest
Novartis, none: Ownership Interest
Insys Therapeutics, none: Ownership Interest
Abbvie, none: Ownership Interest
GW Pharmaceuticals, none: Ownership Interest
Cardinal Health, none: Ownership Interest
Immunomedics, none: Ownership Interest
Endocyte, none: Ownership Interest
Clovis Oncology, none: Ownership Interest
Cellectis, none: Ownership Interest
Aetna, none: Ownership Interest
CVS Health, none: Ownership Interest
Celgene, none: Ownership Interest
Bluebird, none: Ownership Interest
Crisper, none: Ownership Interest
Pfizer, none: Ownership Interest
Idexx Labs, none: Ownership Interest
Vertex, none: Ownership Interest
Nothing to Disclose
medac GmbH, PI:
travel grants to scientific meetings
Lophius Biosciences, independent contractor: Research Funding
Lophius Biosciences, independent contractor: Research Funding
Pharmacyclics, membership on Board of Directors or advisory committees:
Advisory Board
and
Honoraria
Abbvie, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Seattle Genetics, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Novartis, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Genentech, membership on Board of Directors or advisory committees: Advisory Board , Honoraria and Research Funding
Pfizer, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Amgen, independent contractor: Research Funding
Abbvie, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Seattle Genetics, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Novartis, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Genentech, membership on Board of Directors or advisory committees: Advisory Board , Honoraria and Research Funding
Pfizer, membership on Board of Directors or advisory committees: Advisory Board and Honoraria
Amgen, independent contractor: Research Funding
Nothing to Disclose
Exthera Medical, Consultant:
Consultancy
Amplyx, Consultant: Consultancy
Shire, Research Support, Study PI: Research Funding
Nohla therapeutics, Consultant: Consultancy and Research Funding
Karius, Research Support: Research Funding
Shire, Research Support: Research Funding
Amplyx, Consultant: Consultancy
Shire, Research Support, Study PI: Research Funding
Nohla therapeutics, Consultant: Consultancy and Research Funding
Karius, Research Support: Research Funding
Shire, Research Support: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
DAVA Oncology, Lecturer:
Honoraria
Karius, Employee:
Salary
Roy Chemaly, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Consultant:
Consultancy
Jazz Pharmaceuticals, consultant: Consultancy
Jazz Pharmaceuticals, consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Partners Therapeutics, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kariurs, Inc., Head of Clinical Affairs:
Salary
medac GmbH, Investigator:
Consultancy
and
Honoraria
Millennium Takeda, investigator:
Research Funding
Sanofi, investigator: Research Funding
Seattle Genetics, investigator: Research Funding
Merck, investigator: Research Funding
uptodate, contributor: Royalty
Jazz Pharmaceuticals, consultant: Consultancy
NCCN, consultant: Consultancy
Sanofi, investigator: Research Funding
Seattle Genetics, investigator: Research Funding
Merck, investigator: Research Funding
uptodate, contributor: Royalty
Jazz Pharmaceuticals, consultant: Consultancy
NCCN, consultant: Consultancy
Bayer, Gilead, Rigel, .:
Consultancy
Gilead, Celgene, Genentech, Novartis, Seattle Genetics, Unum, .: Research Funding
Gilead, Seattle Genetics, ,: Speakers Bureau
Gilead, Celgene, Genentech, Novartis, Seattle Genetics, Unum, .: Research Funding
Gilead, Seattle Genetics, ,: Speakers Bureau
Nothing to Disclose
Incyte, Advisor:
Advisory Board
BMS, Advisor: Advisory Board
Incyte, Consultant: Advisory Board and Consultancy
BMS, Consultant: Advisory Board
BMS, Advisor: Advisory Board
Incyte, Consultant: Advisory Board and Consultancy
BMS, Consultant: Advisory Board
Novartis, NA:
Advisory Board
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kariurs, Inc., VP of Medical Affairs and Clinical Development:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, investigator:
Research Funding
Novartis, investigator: Research Funding
Novartis, investigator: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, None:
Consultancy
and
Received travel expenses
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Rubius Therapeutics, Inc., Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen, none:
Consultancy
1Mallinckrodt Pharmaceuticals, Sr. Director:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Analytica Laser, Employment:
Salary
Chimerix, Consulting: Consultancy
Chimerix, Consulting: Consultancy
Kite (A Gilead Company), Educational Speaker:
Speakers Bureau
Nothing to Disclose
Nothing to Disclose
Ansun Biopharma, Employee:
Salary
Amgen, Singapore, Speaker:
Honoraria
Johnson and Johnson, Singapore, Advisory Board member: Advisory Board
Johnson and Johnson, Singapore, Advisory Board member: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
I
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, MD:
Research Funding
Abbvie, MD: Research Funding
Kyowa-Hakko Kirin, MD: Research Funding
Bristol-Myers Squibb, MD: Honoraria and Research Funding
MSD, MD: Research Funding
Daiichi Sankyo, MD: Research Funding
Gilead, MD: Research Funding
Teijin Pharma, MD: Research Funding
Astellas, MD: Research Funding
Janssen, MD: Honoraria and Research Funding
Chugai, MD: Research Funding
Ono, MD: Honoraria and Research Funding
Takeda, MD: Honoraria and Research Funding
Celgene, MD: Honoraria and Research Funding
Abbvie, MD: Research Funding
Kyowa-Hakko Kirin, MD: Research Funding
Bristol-Myers Squibb, MD: Honoraria and Research Funding
MSD, MD: Research Funding
Daiichi Sankyo, MD: Research Funding
Gilead, MD: Research Funding
Teijin Pharma, MD: Research Funding
Astellas, MD: Research Funding
Janssen, MD: Honoraria and Research Funding
Chugai, MD: Research Funding
Ono, MD: Honoraria and Research Funding
Takeda, MD: Honoraria and Research Funding
Celgene, MD: Honoraria and Research Funding
Nothing to Disclose
Shire, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Astellas, Speaker:
Speaker Bureau
Merck, Speaker: Speaker Bureau
Merck, Speaker: Speaker Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
J
Nothing to Disclose
Nothing to Disclose
TG Therapeutics, Stock Owenership:
Ownership Interest
TG Therapeutics, Honororia: Honoraria
TG Therapeutics, Research Funding: Research Funding
Juno, Consultant: Consultancy
Gilead, Consultant: Consultancy
Spectrum Pharmaceuticals, Consultant: Consultancy
Pharmacyclics, Research Funding: Research Funding
TG Therapeutics, Honororia: Honoraria
TG Therapeutics, Research Funding: Research Funding
Juno, Consultant: Consultancy
Gilead, Consultant: Consultancy
Spectrum Pharmaceuticals, Consultant: Consultancy
Pharmacyclics, Research Funding: Research Funding
Nothing to Disclose
Bayer, consulting:
Advisory Board
,
Consultancy
,
Honoraria
and
Travel/Accomodations/Expenses
Pfizer, consulting: Advisory Board , Consultancy and Honoraria
Precision Biosciences, consulting: Advisory Board , Consultancy and Honoraria
Novartis, speaking and teaching: Honoraria and Speakers Bureau, Travel/Accomodations/Expenses
Kite, consulting: Advisory Board , Consultancy and Travel/Accomodations/Expenses
Humanigen, consulting: Advisory Board and Consultancy
Cowen, speaking and teaching: Travel/Accomodations/Expenses
Pfizer, consulting: Advisory Board , Consultancy and Honoraria
Precision Biosciences, consulting: Advisory Board , Consultancy and Honoraria
Novartis, speaking and teaching: Honoraria and Speakers Bureau, Travel/Accomodations/Expenses
Kite, consulting: Advisory Board , Consultancy and Travel/Accomodations/Expenses
Humanigen, consulting: Advisory Board and Consultancy
Cowen, speaking and teaching: Travel/Accomodations/Expenses
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Consultancy
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Incyte, Investigator:
Advisory Board
and
Consultancy
Mallinckrodt, Investigator Initiated Study: Research Funding
Kadmon, Investigator: Consultancy
Janssen, Investigator: Research Funding
Incyte Corporation, Advisory board: Advisory Board
Mallinckrodt, Investigator Initiated Study: Research Funding
Kadmon, Investigator: Consultancy
Janssen, Investigator: Research Funding
Incyte Corporation, Advisory board: Advisory Board
Novartis, NA:
Research Funding
Kite Pharma, NA: Advisory Board
Juno, NA: Advisory Board
Kite Pharma, NA: Advisory Board
Juno, NA: Advisory Board
Nothing to Disclose
NIH funding, Other:
Research Funding
Goldilocks, Co founder: Other
Goldilocks, Co founder: Other
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Kite a Gilead Company, Employee:
Ownership Interest
,
Patents
,
Royalty
and
Salary
Amgen, .: Ownership Interest
Amgen, .: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Abbvie, Consultant:
Consultancy
and
Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
BMS, Consultant: Advisory Board , Consultancy and Honoraria
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Janssen, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
SkylineDX, Consultant: Advisory Board , Consultancy and Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
BMS, Consultant: Advisory Board , Consultancy and Honoraria
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Janssen, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
SkylineDX, Consultant: Advisory Board , Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Altor BioScience Corporation, previous director:
Ownership Interest
Seres Therapeutics, Inc., Advisory Board Member:
Advisory Board
and
Intellectual Property Rights
Ziopharm Oncology, Consultant: Consultancy
MicrobiomeDx, Consultant: Consultancy
Ziopharm Oncology, Consultant: Consultancy
MicrobiomeDx, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, Advisory Board:
Advisory Board
INCYTE, Participant:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Velos, Inc, consultant:
Consultancy
and
Ownership Interest
Stafa, Inc, consultant: Consultancy and Ownership Interest
Stafa, Inc, consultant: Consultancy and Ownership Interest
Nothing to Disclose
Novimmune/Sobi:
Advisory Board
,
Consultancy
and
Honoraria
Nothing to Disclose
Pharmerit International, Senior Scientist:
Consultancy
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
K
Novo Nordisk, Consultant:
Consultancy
Immunomedics, Consultant: Consultancy
Immunomedics, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, NA:
Consultancy
Genentech, NA: Consultancy
ADC Therapeutics, NA: Research Funding
Genentech, NA: Consultancy
ADC Therapeutics, NA: Research Funding
Nothing to Disclose
Takeda, MD:
Consultancy
and
Travel
Amgen, MD: Consultancy
Janssen, MD: Consultancy
Celgene, MD: Consultancy and Research Funding
Amgen, MD: Consultancy
Janssen, MD: Consultancy
Celgene, MD: Consultancy and Research Funding
Nothing to Disclose
Bristol-Myers Squibb, Speaker:
Speaking fees
Otsuka, Speaker: Speaking fees
Otsuka, Speaker: Speaking fees
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sancilio, Funding recipient:
Research Funding
AstraZeneca, Board member: Advisory Board
bluebird bio, Inc., Board member / Funding Recipient: Advisory Board and Research Funding
Apopharma, Funding recipient: Research Funding
Global Blood Therapeutics, Funding recipient: Research Funding
Novartis, Board member / Funding Recipient: Advisory Board and Research Funding
Pfizer, Funding recipient: Research Funding
ASH, Board member: Advisory Board
NHLBI, Board member / Funding Recipient: Advisory Board and Research Funding
AstraZeneca, Board member: Advisory Board
bluebird bio, Inc., Board member / Funding Recipient: Advisory Board and Research Funding
Apopharma, Funding recipient: Research Funding
Global Blood Therapeutics, Funding recipient: Research Funding
Novartis, Board member / Funding Recipient: Advisory Board and Research Funding
Pfizer, Funding recipient: Research Funding
ASH, Board member: Advisory Board
NHLBI, Board member / Funding Recipient: Advisory Board and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Taked, Celgene, Nil:
Research Funding
Nothing to Disclose
Actinium Pharmaceuticals, Inc., Chief Commercial Officer:
Ownership Interest
and
Salary
Gilead, review panel:
Honoraria
Alexion, speaking and teaching: Honoraria
Alexion, speaking and teaching: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AstraZeneca, NA:
Speakers Bureau
Gilead, NA: Speakers Bureau
Gilead, NA: Speakers Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Spectrum Pharmaceuticals, Research Funding:
Research Funding
Cytomx Therapeutics, DSMC:
Consultancy
Infinity Pharm, DMSC: Consultancy
Agios Pharm, DSMC: Consultancy
Celgene, DSMC: Consultancy
Morpho Sys, DSMC: Consultancy
Pharmacyclics, Advisory Board: Advisory Board and Research Funding
Janssen, Advisory Board: Advisory Board
Acerta, Research Funding: Research Funding
Tolero Pharm, Research Funding: Research Funding
MEI Pharm, Research Funding: Research Funding
Infinity Pharm, DMSC: Consultancy
Agios Pharm, DSMC: Consultancy
Celgene, DSMC: Consultancy
Morpho Sys, DSMC: Consultancy
Pharmacyclics, Advisory Board: Advisory Board and Research Funding
Janssen, Advisory Board: Advisory Board
Acerta, Research Funding: Research Funding
Tolero Pharm, Research Funding: Research Funding
MEI Pharm, Research Funding: Research Funding
Bristol Myers Squibb, None:
Intellectual Property Rights
and
Research Funding
Kymab, None: Consultancy and Research Funding
Magenta, None: Advisory Board and Consultancy
Equillium, None: Consultancy
Regeneron, None: Research Funding
Fortyseven, None: Consultancy
EMDSerono, None: Consultancy
Bioverativ, None: Consultancy
Kymab, None: Consultancy and Research Funding
Magenta, None: Advisory Board and Consultancy
Equillium, None: Consultancy
Regeneron, None: Research Funding
Fortyseven, None: Consultancy
EMDSerono, None: Consultancy
Bioverativ, None: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cynata Therapeutics Limited, Management positions:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Support:
Consultancy
Nothing to Disclose
Nothing to Disclose
Novartis, Royalty and Patent:
Financial Benefit and/or patents
and
Royalty
Tolero Pharmaceuticals, Inc., Research Funding: Research Funding
Humanigen, Research Funding: Research Funding
Novartis, Royalty and Patent: Financial Benefit and/or patents , Intellectual Property Rights and Royalty
Tolero Pharmaceuticals, Inc., Research Funding: Research Funding
Humanigen, Research Funding: Research Funding
Novartis, Royalty and Patent: Financial Benefit and/or patents , Intellectual Property Rights and Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gentium, Support:
Research Funding
The National Cancer Institute of the National Institutes of Health, Support: Research Funding
Jazz Pharmaceuticals, Support: Research Funding
The National Cancer Institute of the National Institutes of Health, Support: Research Funding
Jazz Pharmaceuticals, Support: Research Funding
Nothing to Disclose
Roche, Advisor:
Advisory Board
,
Honoraria
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead, Consultant:
Advisory Board
,
Consultancy
and
Honoraria
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Seattle genetics, Consultant: Advisory Board , Consultancy and Honoraria
Roche, Consultant: Advisory Board , Consultancy and Honoraria
Abbvie, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Seattle genetics, Consultant: Advisory Board , Consultancy and Honoraria
Roche, Consultant: Advisory Board , Consultancy and Honoraria
Abbvie, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Conquer Cancer Foundation of ASCO/Gilead Sciences, Inc., Investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pharmacyclics:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Rocket Pharmaceuticals, Consultant:
Consultancy
Homology Medicine, Consultant: Consultancy
Magenta, Consultant: Consultancy
Magenta, Consultant: Consultancy and Research Funding
Homology Medicine, Consultant: Consultancy
Magenta, Consultant: Consultancy
Magenta, Consultant: Consultancy and Research Funding
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Bristol Myers Squibb, Consultancy:
Consultancy
Bristol Myers Squibb, Honoraria: Honoraria
Bristol Myers Squibb, Research: Research Funding
Novartis, Consultancy: Consultancy
Novartis, Honoraria: Honoraria
Novartis, Research: Research Funding
Paladin, Consultancy: Consultancy
Pfizer, Consultancy: Consultancy
Bristol Myers Squibb, Honoraria: Honoraria
Bristol Myers Squibb, Research: Research Funding
Novartis, Consultancy: Consultancy
Novartis, Honoraria: Honoraria
Novartis, Research: Research Funding
Paladin, Consultancy: Consultancy
Pfizer, Consultancy: Consultancy
Nothing to Disclose
Kite, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Indapta Therapeutics, Inc., consulting, membership on Scientific Advisory Board:
Advisory Board
,
Consultancy
,
Financial Benefit and/or patents
,
Intellectual Property Rights
and
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracor Eurofins, Employee:
Salary
Viracor Eurofins Clinical Diagnostics, Vice President, Research and Development:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Kite, Honoraria:
Honoraria
iTeos, Research funding: Research Funding
Merck, Research funding: Honoraria and Research Funding
Seattle Genetics, Honoraria: Honoraria
iTeos, Research funding: Research Funding
Merck, Research funding: Honoraria and Research Funding
Seattle Genetics, Honoraria: Honoraria
Nothing to Disclose
ABBOTT, For presentation:
Honoraria
Gilead, For presentation: Honoraria
Gilead, For presentation: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Orchard Therapeutics Ltd., Consultant, SAB Member:
Advisory Board
,
Consultancy
and
Research Funding
Allogene Therapeutics, SAB Member: Advisory Board
National Institutes of Health, Researcher: Research Funding
Allogene Therapeutics, SAB Member: Advisory Board
National Institutes of Health, Researcher: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite/Gilead, Ad Hoc Consultant:
Advisory Board
,
Consultancy
and
Research Funding
Novartis, Ad Hoc Consultant: Advisory Board , Consultancy and Research Funding
Malinckrodt, Educational Speaker: Honoraria
Atara, Ad Hoc Consultant: Consultancy and Honoraria
Juno/Celgene, Ad Hoc Consultant: Advisory Board and Consultancy
Novartis, Ad Hoc Consultant: Advisory Board , Consultancy and Research Funding
Malinckrodt, Educational Speaker: Honoraria
Atara, Ad Hoc Consultant: Consultancy and Honoraria
Juno/Celgene, Ad Hoc Consultant: Advisory Board and Consultancy
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
amgen, consultant:
Consultancy
prometheus labs, research funding: Research Funding
bms, research support: Research Funding
miltenyi biotec, research support: Research Funding
equillium inc, consulting: Consultancy
cugene, consulting: Consultancy
fortress biotech, consulting: Consultancy
prometheus labs, research funding: Research Funding
bms, research support: Research Funding
miltenyi biotec, research support: Research Funding
equillium inc, consulting: Consultancy
cugene, consulting: Consultancy
fortress biotech, consulting: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, None:
Consultancy
,
Ownership Interest
and
Speaker's Bureau
Janssen, None: Consultancy and Speaker's bureau
Takeda, None: Consultancy and Speaker's Bureau
Onyx, None: Speaker's bureau
Sutro Biopharma, None: Advisory Board
zPredicta, None: Advisory Board
Janssen, None: Consultancy and Speaker's bureau
Takeda, None: Consultancy and Speaker's Bureau
Onyx, None: Speaker's bureau
Sutro Biopharma, None: Advisory Board
zPredicta, None: Advisory Board
Nothing to Disclose
Nothing to Disclose
Celgene, none:
Honoraria
and
Research Funding
Novartis, none: Honoraria and Research Funding
JAZZ, none: Honoraria
Sanofi, none: Honoraria
Neovii, none: Honoraria and Research Funding
Riemser, none: Honoraria and Research Funding
Novartis, none: Honoraria and Research Funding
JAZZ, none: Honoraria
Sanofi, none: Honoraria
Neovii, none: Honoraria and Research Funding
Riemser, none: Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lentigen Technology, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, None:
Consultancy
and
Research Funding
Celgene, None: Consultancy and Research Funding
Abbvie, None: Consultancy and Research Funding
Genentech, None: Consultancy and Research Funding
KITE, None: Consultancy and Research Funding
Medimmune, None: Research Funding
Novartis, None: Research Funding
Janssen, None: Consultancy and Research Funding
Sanofi, None: Research Funding
BMS, None: Research Funding
Oncopeptides, None: Consultancy
Adaptive, None: Consultancy
Reddys Lab, None: Honoraria
Celgene, Takeda, Janssen, BMS, Sanofi, Kite, Merck, Abbvie, MedImmune, Novartis, Roche-Genentech, Amgen, Principal Investigator: Research support to institution
Celgene, Takeda, Janssen, Kite, Merck, Abbvie, MedImmune, Genentech, Amgen, Advisory Board, Consulting: Honorarium to institution
Reddy's Lab, Speaking: Honoraria
Celgene, None: Consultancy and Research Funding
Abbvie, None: Consultancy and Research Funding
Genentech, None: Consultancy and Research Funding
KITE, None: Consultancy and Research Funding
Medimmune, None: Research Funding
Novartis, None: Research Funding
Janssen, None: Consultancy and Research Funding
Sanofi, None: Research Funding
BMS, None: Research Funding
Oncopeptides, None: Consultancy
Adaptive, None: Consultancy
Reddys Lab, None: Honoraria
Celgene, Takeda, Janssen, BMS, Sanofi, Kite, Merck, Abbvie, MedImmune, Novartis, Roche-Genentech, Amgen, Principal Investigator: Research support to institution
Celgene, Takeda, Janssen, Kite, Merck, Abbvie, MedImmune, Genentech, Amgen, Advisory Board, Consulting: Honorarium to institution
Reddy's Lab, Speaking: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
CBA, President:
association
Cryo-Cell, Medical Director: cord blood bank
Marcus Foundation, PI: Research Funding
Robertsion Foundation, PI: Research Funding
HRSA, PI: Research Funding
Cryo-Cell, Medical Director: cord blood bank
Marcus Foundation, PI: Research Funding
Robertsion Foundation, PI: Research Funding
HRSA, PI: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Bio-Rad Laboratories, Inc., Consultant for new molecular diagnostic platform:
Consultancy
Agios Pharmaceuticals, Consultant:
Consultancy
and
Research Funding
Novartis, Funding recipient: Research Funding
Apopharma, Funding recipient: Research Funding
Terumo, Funding recipient: Research Funding
bluebird bio, Inc., consultant: Consultancy , Honoraria and Research Funding
Agios Pharmaceuticals, Consultant / Funding recipient: Consultancy and Research Funding
bluebird bio, Inc., Consultant / Funding recipient: Consultancy , Honoraria and Research Funding
Novartis, Funding recipient: Research Funding
Apopharma, Funding recipient: Research Funding
Terumo, Funding recipient: Research Funding
bluebird bio, Inc., consultant: Consultancy , Honoraria and Research Funding
Agios Pharmaceuticals, Consultant / Funding recipient: Consultancy and Research Funding
bluebird bio, Inc., Consultant / Funding recipient: Consultancy , Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
L
Nothing to Disclose
Nothing to Disclose
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, MD:
Salary
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Novartis, Advisory Board Member:
Advisory Board
and
Consultancy
Loxo Oncology, Advisory Board Member: Advisory Board and Consultancy
Bayer, Advisory Board Member: Advisory Board and Consultancy
Eli Lilly, Advisory Board Member: Advisory Board and Consultancy
Loxo Oncology, Advisory Board Member: Advisory Board and Consultancy
Bayer, Advisory Board Member: Advisory Board and Consultancy
Eli Lilly, Advisory Board Member: Advisory Board and Consultancy
Nothing to Disclose
Nothing to Disclose
Cidara, Contracted Researcher:
Research Funding
Nothing to Disclose
Optum, Inc, Research:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Heron Therapeutics, advisor:
Advisory Board
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, none:
Advisory Board
and
Research Funding
Celgene, none: Advisory Board
Janssen, none: Advisory Board
Spectrum pharmaceuticals, none: Advisory Board and Research Funding
Caelum Biosciences, none: Advisory Board and Consultancy
Amgen, none: Research Funding
Prothena, none: Advisory Board and Consultancy
Celgene, none: Advisory Board
Janssen, none: Advisory Board
Spectrum pharmaceuticals, none: Advisory Board and Research Funding
Caelum Biosciences, none: Advisory Board and Consultancy
Amgen, none: Research Funding
Prothena, none: Advisory Board and Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Employee:
Salary
Medac, none:
Research Funding
Neovii, none: Advisory Board
Neovii, none: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Consulting:
Consultancy
Viracor-Eurofins, Research: Organization ran research samples for free
Viracor-Eurofins, Research: Organization ran research samples for free
Nothing to Disclose
Nothing to Disclose
Kite: Gilead, speakers bureau:
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Ansun Biopharma, Investigator:
Research grant
Nothing to Disclose
Actinium, Consultant:
Consultancy
and
Honoraria
Jazz Pharmaceuticals, Consulting and Speaking: Stipend
Jazz Pharmaceuticals, Consulting and Speaking: Stipend
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
NeoImmuneTech, Principal Scientist:
Intellectual Property Rights
,
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Intrexon Corp, None:
Intellectual Property Rights
Ziopharm Oncology, None: Intellectual Property Rights
Ziopharm Oncology, Consultant: Consultancy
Intellia Therapeutics, Consultant: Consultancy
Jazz Pharmaceuticals, Consultant: Consultancy
Shire US, Advisory Board: Advisory Board and Consultancy
Courier Therapeutics, Advisory Board: Advisory Board and Consultancy
Cyto-Sen Therapeutics, Founder, VP, Medical Director: Ownership Interest
Medac Pharma, Advisory Board: Consultancy and Travel reimbursement
Miltenyi, Speaker: Honoraria
Ziopharm Oncology, None: Intellectual Property Rights
Ziopharm Oncology, Consultant: Consultancy
Intellia Therapeutics, Consultant: Consultancy
Jazz Pharmaceuticals, Consultant: Consultancy
Shire US, Advisory Board: Advisory Board and Consultancy
Courier Therapeutics, Advisory Board: Advisory Board and Consultancy
Cyto-Sen Therapeutics, Founder, VP, Medical Director: Ownership Interest
Medac Pharma, Advisory Board: Consultancy and Travel reimbursement
Miltenyi, Speaker: Honoraria
Nothing to Disclose
Kite, employment:
Ownership Interest
,
Salary
and
Travel, Accomodations, Expenses
Caladrius Biosciences, employment: Ownership Interest and Salary
Caladrius Biosciences, employment: Ownership Interest and Salary
NantKwest, Sr. Vice president:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracyte, Equity Ownership:
Ownership Interest
ViraCyte, Co-founder: Consultancy and Ownership Interest
Marker, Co-founder: Ownership Interest
ViraCyte, Co-founder: Consultancy and Ownership Interest
Marker, Co-founder: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employee:
Salary
Nothing to Disclose
Viracor, Patent:
Royalty
Viracor, Patent: Intellectual Property Rights and Royalty
Therakos, Consultant: Consultancy
Novartis, Consultant: Consultancy
Ironwood, Consultant: Consultancy
Incyte, Consultant: Consultancy
Bluebird, Consultant: Consultancy
Viracor, GVHD biomarker patent: Financial Benefit and/or patents , Intellectual Property Rights and Royalty
Viracor, Patent: Intellectual Property Rights and Royalty
Therakos, Consultant: Consultancy
Novartis, Consultant: Consultancy
Ironwood, Consultant: Consultancy
Incyte, Consultant: Consultancy
Bluebird, Consultant: Consultancy
Viracor, GVHD biomarker patent: Financial Benefit and/or patents , Intellectual Property Rights and Royalty
Novartis, Consultancy:
Consultancy
Novartis, Research: Research Funding
Novartis, Honoraria: Honoraria
Astellas, Consultancy: Consultancy
Astellas, Research: Research Funding
FujiFilm, Research: Research Funding
Daiichi-Sankyo, Consultancy: Consultancy
Novartis, Research: Research Funding
Novartis, Honoraria: Honoraria
Astellas, Consultancy: Consultancy
Astellas, Research: Research Funding
FujiFilm, Research: Research Funding
Daiichi-Sankyo, Consultancy: Consultancy
Nothing to Disclose
Nothing to Disclose
Heat Biologics, Scientific advisory board member:
Advisory Board
,
Consultancy
,
Financial Benefit and/or patents
and
Research Funding
Pelican Therapeutics, Consultant: Consultancy
Pelican Therapeutics, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Sr. Principal Scientist, Translational Sciences:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Juno Therapeutics, Statistician:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, Consultant and Investigator:
Consultancy
and
Research Funding
Astellas Pharma Inc, Consultant and Investigator: Consultancy
Helocyte Inc, Consultant: Consultancy
Astellas Pharma Inc, Consultant and Investigator: Consultancy
Helocyte Inc, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Acadia Pharmaceuticals, Shareholder:
Ownership Interest
Bellicum Pharmaceuticals, Shareholder: Ownership Interest
Citius Pharmaceuticals, Shareholder: Ownership Interest
Teligent Pharmaceuticals, Shareholder: Ownership Interest
Guidepoint Global, Advisor: Consultancy
Bellicum Pharmaceuticals, Shareholder: Ownership Interest
Citius Pharmaceuticals, Shareholder: Ownership Interest
Teligent Pharmaceuticals, Shareholder: Ownership Interest
Guidepoint Global, Advisor: Consultancy
Jazz, Honoraria:
Honoraria
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Chimerix, Medical advisor:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Theravance, Member of Independent Efficacy Adjudication Committee:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
UC Davis, Graduate Research Assistant:
Collaborator
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, Speaking, advisory board member:
Advisory Board
and
Honoraria
Miltenyi, Speaking: Honoraria
Novartis, Consultant: Advisory Board and Consultancy
bluebird bio, Inc., Consultant: Consultancy
Bellicum, Consultant, advisory board member: Advisory Board and Consultancy
bluebird bio, Consultant: Consultancy
Miltenyi, Speaking: Honoraria
Novartis, Consultant: Advisory Board and Consultancy
bluebird bio, Inc., Consultant: Consultancy
Bellicum, Consultant, advisory board member: Advisory Board and Consultancy
bluebird bio, Consultant: Consultancy
Kite, member:
Advisory Board
Novatis, member: Advisory Board
Cellular Biomedicine Group Inc, Consultancy: Consultancy
Novatis, member: Advisory Board
Cellular Biomedicine Group Inc, Consultancy: Consultancy
Nothing to Disclose
Amgen, .:
Consultancy
Jazz Pharmaceuticals, .: Consultancy and Research Funding
Incyte, .: Consultancy
Novartis, .: Consultancy and Research Funding
Pfizer, .: Consultancy
Shire, .: Consultancy
Astellas, .: Research Funding
Pharmacyclics, .: Research Funding
Kite a Gilead Company, .: Research Funding
Napajen, .: Consultancy
Adaptive Biotech, .: Consultancy
Jazz Pharmaceuticals, .: Consultancy and Research Funding
Incyte, .: Consultancy
Novartis, .: Consultancy and Research Funding
Pfizer, .: Consultancy
Shire, .: Consultancy
Astellas, .: Research Funding
Pharmacyclics, .: Research Funding
Kite a Gilead Company, .: Research Funding
Napajen, .: Consultancy
Adaptive Biotech, .: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Insight-rx, scientific advisor:
Consultancy
Nothing to Disclose
Nothing to Disclose
Hospital Israelita Albert Einstein, dentist:
dentist
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz, Employee:
Intellectual Property Rights
,
Ownership Interest
,
Royalty
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracor-Eurofins, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Actinium Pharmaceuticals, Inc., Chief Scientific Officer:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, NA:
Research Funding
Magenta Therapeutics, Study Investigator: Research Funding
Magenta Therapeutics, Study Investigator: Research Funding
Nothing to Disclose
Pharmerit International, Health Outcomes SAS Programmer:
Consultancy
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Windmiltherapheutics, nothing:
Intellectual Property Rights
Nothing to Disclose
Juno Therapeutics, Statistician:
Ownership Interest
and
Salary
Nothing to Disclose
Incyte, Research Funding:
Research Funding
Johnson Graffe Keay Moniz and Wick LLP, Consulting: Consultancy
Juno Therapeutics, Research Funding: Research Funding
Rhizen Pharmaceuticals, Research Funding: Research Funding
Takeda, Research Funding: Research Funding
TG Therapeutics, Research Funding: Research Funding
Johnson Graffe Keay Moniz and Wick LLP, Consulting: Consultancy
Juno Therapeutics, Research Funding: Research Funding
Rhizen Pharmaceuticals, Research Funding: Research Funding
Takeda, Research Funding: Research Funding
TG Therapeutics, Research Funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
M
Nothing to Disclose
Novartis, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
CIBMTR, VP, Biomedical Informatics:
Research Funding
Juno, None:
Research Funding
Janssen, None: Research Funding
Takeda, None: Research Funding
Physician Education Resource, None: Honoraria
Janssen, None: Research Funding
Takeda, None: Research Funding
Physician Education Resource, None: Honoraria
Genentech, Consulting and speaking:
Consultancy
Regeneron, Consulting and speaking: Consultancy
Regeneron, Consulting and speaking: Consultancy
Nothing to Disclose
Anthem, Inc, Consultant:
Consultancy
Atara Bio, Advisory Board: Advisory Board and Honoraria
Incyte, Advisory Board: Advisory Board and Honoraria
Anthem Inc, Consultant: Consultancy
Atara Bio, Advisory Board: Advisory Board and Honoraria
Incyte, Advisory Board: Advisory Board and Honoraria
Anthem Inc, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Orchard Therapeutics, Honoraria:
Advisory Board
Amgen, Speaker:
Honoraria
Celgene, Advisory Board/Speaker: Advisory Board and Honoraria
Takeda, Advisory Board /Speaker: Advisory Board and Honoraria
Sanofi, Advisory Board: Advisory Board
Janssen, Advisory Board/Speaker: Advisory Board and Honoraria
Celgene, Advisory Board/Speaker: Advisory Board and Honoraria
Takeda, Advisory Board /Speaker: Advisory Board and Honoraria
Sanofi, Advisory Board: Advisory Board
Janssen, Advisory Board/Speaker: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Juno Therapeutics, Research Funding:
Research Funding
Janssen Scientific Affairs, Honoraria: Honoraria
Seattle Genetics, Honoraria: Honoraria
Roche/Genentech, Honoraria: Honoraria
GlaxoSmithKline, Research Funding: Research Funding
Janssen Scientific Affairs, Honoraria: Honoraria
Seattle Genetics, Honoraria: Honoraria
Roche/Genentech, Honoraria: Honoraria
GlaxoSmithKline, Research Funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Tesaro & Taiho, consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite a Gilead Company, Employee:
Ownership Interest
,
Salary
and
Travel, Accommodations, Expenses
Mustang Bio, .: Patents & Royalties
Mustang Bio, .: Patents & Royalties
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Consultant:
Advisory Board
,
Consultancy
,
Honoraria
and
Research Funding
Takeda, Consultant: Consultancy
Amgen, Consultant: Consultancy
Janssen, Consultant: Consultancy and Research Funding
Takeda, Consultant: Consultancy
Amgen, Consultant: Consultancy
Janssen, Consultant: Consultancy and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck and Co, Inc, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Chimerix, Investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Shire, Employee:
Salary
Procter and Gamble, Stock ownership:
Ownership Interest
Pfizer, DSMB Member: Data and Safety Monitoring Board
Neovii, Investigator: Research Funding
Pfizer, DSMB member: Consultancy
Genentech, Consultant: Consultancy
Incyte, Advisory Board: Advisory Board
Procter and Gambel, Ownership: Ownership Interest
AbGenomics, Investigator: Research Funding
Pfizer, DSMB Member: Data and Safety Monitoring Board
Neovii, Investigator: Research Funding
Pfizer, DSMB member: Consultancy
Genentech, Consultant: Consultancy
Incyte, Advisory Board: Advisory Board
Procter and Gambel, Ownership: Ownership Interest
AbGenomics, Investigator: Research Funding
Jazz Pharmaceuticals, Local PI:
Research Funding
Novartis, Local PI: Research Funding
Novartis, Local PI: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Ansun Biopharma, Investigator:
Research grant
Nothing to Disclose
Nothing to Disclose
Incyte, Membership on entity's board of directors:
Advisory Board
and
Research Funding
Novartis, Funding: Research Funding
Promedior, Funding: Research Funding
Roche, Funding: Research Funding
Merck, Funding: Research Funding
CTI Biopharma, Membership on entity's board of directors: Advisory Board and Research Funding
Janssen, Funding: Research Funding
Celgene, Membership on entity's board of directors: Advisory Board
Novartis, Funding: Research Funding
Promedior, Funding: Research Funding
Roche, Funding: Research Funding
Merck, Funding: Research Funding
CTI Biopharma, Membership on entity's board of directors: Advisory Board and Research Funding
Janssen, Funding: Research Funding
Celgene, Membership on entity's board of directors: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck and Co, Inc, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Genentech, none:
Honoraria
and
Research Funding
Roche, none: Honoraria and Research Funding
Bayer, none: Honoraria and Research Funding
Janssen, none: Honoraria and Research Funding
Pharmacyclics, none: Research Funding
Seattle Genetics, none: Honoraria and Research Funding
Rocket, none: Honoraria
Roche, none: Honoraria and Research Funding
Bayer, none: Honoraria and Research Funding
Janssen, none: Honoraria and Research Funding
Pharmacyclics, none: Research Funding
Seattle Genetics, none: Honoraria and Research Funding
Rocket, none: Honoraria
Takeda, MD:
Personal Fees
Janssen, MD: Personal Fees
AMGEN, MD: Personal Fees
Celgene, MD: Personal Fees
GSK, MD: Personal Fees
Abbvie, MD: Personal Fees
Janssen, MD: Personal Fees
AMGEN, MD: Personal Fees
Celgene, MD: Personal Fees
GSK, MD: Personal Fees
Abbvie, MD: Personal Fees
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, Advisory board:
Advisory Board
Novartis, Advisory board: Advisory Board and Research Funding
Novartis, Advisory board: Advisory Board and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Honoraria:
Consultancy
Incyte, Honoraria: Consultancy
Kite/Gilead, Honoraria: Advisory Board
Celgene/Juno, Honoraria: Consultancy
Celgene/Juno, Honoraria: Advisory Board
Novartis, Research Support: Research Funding
Celgene/Juno, Research Support: Research Funding
Incyte, Honoraria: Advisory Board
Celgene/Juno, Honoraria: Advisory Board and Consultancy
Incyte, Honoraria: Advisory Board and Consultancy
Novartis, Inc, Consulting: Consultancy
Incyte, Inc, Consulting: Consultancy
Kite/Gilead, Membership on advisory committees: Honoraria
Celgene/Juno, Inc, Consulting: Consultancy
Celgene/Juno, Inc, Membership on advisory committees: Honoraria
Novartis, Inc, Research Support: Research Funding
Celgene/Juno, Inc, Research Support: Research Funding
Incyte, Inc, Membership on advisory committees: Honoraria
Kite Therapeutics, Honoraria: Honoraria
Juno Therapeutics, Honoraria: Honoraria
Juno Therapeutics, Consultancy: Consultancy
Incyte, Honoraria: Honoraria
Incyte, Consultancy: Consultancy
Novartis, Research Funding: Research Funding
Novartis, Membership: Advisory Committee
Novartis, Honoraria: Honoraria
Athersys, Inc., Patents and Royalties: Financial Benefit and/or patents and Royalty
Incyte, Honoraria: Consultancy
Kite/Gilead, Honoraria: Advisory Board
Celgene/Juno, Honoraria: Consultancy
Celgene/Juno, Honoraria: Advisory Board
Novartis, Research Support: Research Funding
Celgene/Juno, Research Support: Research Funding
Incyte, Honoraria: Advisory Board
Celgene/Juno, Honoraria: Advisory Board and Consultancy
Incyte, Honoraria: Advisory Board and Consultancy
Novartis, Inc, Consulting: Consultancy
Incyte, Inc, Consulting: Consultancy
Kite/Gilead, Membership on advisory committees: Honoraria
Celgene/Juno, Inc, Consulting: Consultancy
Celgene/Juno, Inc, Membership on advisory committees: Honoraria
Novartis, Inc, Research Support: Research Funding
Celgene/Juno, Inc, Research Support: Research Funding
Incyte, Inc, Membership on advisory committees: Honoraria
Kite Therapeutics, Honoraria: Honoraria
Juno Therapeutics, Honoraria: Honoraria
Juno Therapeutics, Consultancy: Consultancy
Incyte, Honoraria: Honoraria
Incyte, Consultancy: Consultancy
Novartis, Research Funding: Research Funding
Novartis, Membership: Advisory Committee
Novartis, Honoraria: Honoraria
Athersys, Inc., Patents and Royalties: Financial Benefit and/or patents and Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
National Marrow Donor Program, Vice President, Donor & Collection Services:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, VP:
Intellectual Property Rights
,
Ownership Interest
and
Salary
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pluristem Ltd, NA:
Research Funding
Gamida Cell, NA: Research Funding
Bellicum Pharmaceuticals, NA: Research Funding
Astellas Pharma, NA: Research Funding
Fresenius Biotech, NA: Research Funding
Kite Pharma, NA: Consultancy , Honoraria and Research Funding
Novartis, NA: Consultancy
Kite/Gilead, Personal fees: Honoraria and Travel, accommodations, expenses
Kite/Gilead, Research Support: Advisory Board and Speaker
Celgene/Juno, Honoraria: Advisory Board
Astellas Pharma, Research Support: Research Funding
Bellicum Pharmaceuticals, Research Support: Research Funding
Fresenius Biotech, Research Support: Research Funding
Gamida Cell, Research Support: Research Funding
Pluristem Ltd, Research Support: Research Funding
Novartis, Research Support: Research Funding
ArticulateScience LLC: Assistance with Manuscript preparation
Gamida Cell, NA: Research Funding
Bellicum Pharmaceuticals, NA: Research Funding
Astellas Pharma, NA: Research Funding
Fresenius Biotech, NA: Research Funding
Kite Pharma, NA: Consultancy , Honoraria and Research Funding
Novartis, NA: Consultancy
Kite/Gilead, Personal fees: Honoraria and Travel, accommodations, expenses
Kite/Gilead, Research Support: Advisory Board and Speaker
Celgene/Juno, Honoraria: Advisory Board
Astellas Pharma, Research Support: Research Funding
Bellicum Pharmaceuticals, Research Support: Research Funding
Fresenius Biotech, Research Support: Research Funding
Gamida Cell, Research Support: Research Funding
Pluristem Ltd, Research Support: Research Funding
Novartis, Research Support: Research Funding
ArticulateScience LLC: Assistance with Manuscript preparation
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Fate Therapeutics, Research Funding:
Research Funding
Gamida, Research Funding: Research Funding
Intima, Research Funding: Research Funding
National Cord Blood Association, DSMB Member: DSMB Board Member
B-Mogen, Scientific Advisory Board: Advisory Board
Erytech, Scientific Advisory Board: Advisory Board
Gamida, Research Funding: Research Funding
Intima, Research Funding: Research Funding
National Cord Blood Association, DSMB Member: DSMB Board Member
B-Mogen, Scientific Advisory Board: Advisory Board
Erytech, Scientific Advisory Board: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, employee:
Salary
Biocardia, CSO:
Salary
Cell Med Consulting, Consultant: Consultancy
Oncocyclist, CSO: Ownership Interest
Cell Med Consulting, Consultant: Consultancy
Oncocyclist, CSO: Ownership Interest
Nothing to Disclose
Kite, Membership on Board of Directors or advisory committees:
Advisory Board
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Novartis, Advisor:
Travel
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kiadis Pharma, Medical Writer:
Salary
Nothing to Disclose
Nothing to Disclose
Orthogon Therapeutics, Board member:
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, Honorarium received:
Honoraria
Neovii Biotech, Honorarium received: Honoraria
Neovii Biotech, Honorarium received: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gigagen, Advisor:
Advisory Board
and
Ownership Interest
Triursus therapeutics, Advisor: Advisory Board and Ownership Interest
Orca therapeutics, Advisor: Research Funding
Incyte, Advisor: Advisory Board and Honoraria
Triursus therapeutics, Advisor: Advisory Board and Ownership Interest
Orca therapeutics, Advisor: Research Funding
Incyte, Advisor: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
medac GmbH, Investigator:
travel grants for scientific meetings
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Janssen, advisory & research:
Consultancy
and
Research Funding
Pharmacyclics, advisory & research: Consultancy and Research Funding
Kite - Gilead, research and Avisory: Consultancy and Research Funding
Novartis, advisory: Consultancy
Juno, advisory: Consultancy
adaptive Biotechnologies, advisory & research: Consultancy and Research Funding
Genentech, research: Research Funding
Kite, consulting: Advisory Board , Consultancy , Research Funding and Travel/Accommodations/Expenses
Gilead, consulting: Advisory Board and Consultancy
Pharmacyclics, consulting: Advisory Board , Consultancy , Financial Benefit and/or patents , Research Funding and Travel/Accommodations/Expenses
Janssen, consulting: Advisory Board , Consultancy , Research Funding and Travel/Accommodations/Expenses
Adaptive Biotechnologies, consulting: Advisory Board , Consultancy , Research Funding and Travel/Accommodations/Expenses
Novartis, speaking and teaching: Travel/Accommodations/Expenses
Pharmacyclics, advisory & research: Consultancy and Research Funding
Kite - Gilead, research and Avisory: Consultancy and Research Funding
Novartis, advisory: Consultancy
Juno, advisory: Consultancy
adaptive Biotechnologies, advisory & research: Consultancy and Research Funding
Genentech, research: Research Funding
Kite, consulting: Advisory Board , Consultancy , Research Funding and Travel/Accommodations/Expenses
Gilead, consulting: Advisory Board and Consultancy
Pharmacyclics, consulting: Advisory Board , Consultancy , Financial Benefit and/or patents , Research Funding and Travel/Accommodations/Expenses
Janssen, consulting: Advisory Board , Consultancy , Research Funding and Travel/Accommodations/Expenses
Adaptive Biotechnologies, consulting: Advisory Board , Consultancy , Research Funding and Travel/Accommodations/Expenses
Novartis, speaking and teaching: Travel/Accommodations/Expenses
bluebird bio, Inc., Employee:
Ownership Interest
and
Salary
Nothing to Disclose
GT Biopharma Inc, consultant, contracted research:
Consultancy
,
Intellectual Property Rights
and
Research Funding
Dr. Reddy's Laboratories, Scientific Advisory Board: Consultancy
Onkimmune, Scientific Advisory Board: Advisory Board
CytoSem, Scientific Advisory Board: Advisory Board
Fate Therapeutics, consultant, contracted research: Consultancy , Intellectual Property Rights and Research Funding
Dr. Reddy's Laboratories, Scientific Advisory Board: Consultancy
Onkimmune, Scientific Advisory Board: Advisory Board
CytoSem, Scientific Advisory Board: Advisory Board
Fate Therapeutics, consultant, contracted research: Consultancy , Intellectual Property Rights and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sangamo Therapeutics, Medical Director/Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, PI:
Research Funding
Astrazeneca, PI: Research Funding
Astrazeneca, PI: Research Funding
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Support:
Honoraria
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Johnson and Johnson, Equity interest:
Ownership Interest
Novartis, Equity interest: Ownership Interest
Quest Diagnostics, Equity Interest: Ownership Interest
Novartis, Equity interest: Ownership Interest
Quest Diagnostics, Equity Interest: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda, MD:
Advisory Board
and
Honoraria
Celgene, MD: Advisory Board and Honoraria
Amgen, MD: Advisory Board and Honoraria
Janssen, MD: Advisory Board and Honoraria
Abbvie, MD: Advisory Board and Honoraria
Celgene, MD: Advisory Board and Honoraria
Amgen, MD: Advisory Board and Honoraria
Janssen, MD: Advisory Board and Honoraria
Abbvie, MD: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AbbVie, Consultant:
Advisory Board
and
Consultancy
Adaptive, Consultant: Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
BMS, Consultant: Advisory Board , Consultancy and Honoraria
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Janssen, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
Adaptive, Consultant: Honoraria
Amgen, Consultant: Advisory Board , Consultancy and Honoraria
BMS, Consultant: Advisory Board , Consultancy and Honoraria
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Janssen, Consultant: Advisory Board , Consultancy and Honoraria
Takeda, Consultant: Advisory Board , Consultancy and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Astellas, Advisory Committee:
Advisory Board
Chimerix, Advisory committee, Research Support: Advisory Board and Research Funding
Merck, Advisory Committee: Advisory Board
Chimerix, Advisory committee, Research Support: Advisory Board and Research Funding
Merck, Advisory Committee: Advisory Board
KITE Pharma, Consultant:
speaker for nursing education
Juno, Consultant: Advisory Board
Juno, Consultant: Advisory Board
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Astra Zeneca, none:
Advisory Board
Merck, none: Advisory Board
BMS, none: Advisory Board
Takeda, none: Advisory Board
Seattle Genetics, none: Advisory Board and Research Funding
ADC therapeutics, none: Research Funding
Merck, none: Advisory Board
BMS, none: Advisory Board
Takeda, none: Advisory Board
Seattle Genetics, none: Advisory Board and Research Funding
ADC therapeutics, none: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Tolero Pharmaceuticals, Inc., Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Scientist, Translational Sciences:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead, speaking and teaching:
speakers bureau
Bayer, speaking and teaching: Consultancy , Honoraria and speakers bureau
Kite, speaking and teaching: Consultancy , Honoraria and speakers bureau
Juno, consulting: Consultancy and Honoraria
Genentech, consulting: Consultancy and Honoraria
Pharmacyclics, consulting: Consultancy and Honoraria
Alexion, consulting: Consultancy
Pfizer, consulting: Consultancy
Janssen, consulting: Consultancy
Bristol-Myers Squibb, consulting: Consultancy
Bayer, speaking and teaching: Consultancy , Honoraria and speakers bureau
Kite, speaking and teaching: Consultancy , Honoraria and speakers bureau
Juno, consulting: Consultancy and Honoraria
Genentech, consulting: Consultancy and Honoraria
Pharmacyclics, consulting: Consultancy and Honoraria
Alexion, consulting: Consultancy
Pfizer, consulting: Consultancy
Janssen, consulting: Consultancy
Bristol-Myers Squibb, consulting: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Consultant:
Consultancy
Nothing to Disclose
Bellicum Pharmaceuticals, None:
Advisory Board
Novartis, None: Advisory Board
Novartis, None: Advisory Board
Nothing to Disclose
Nothing to Disclose
N
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte Corporation, Employee:
Salary
and
Stock
Nothing to Disclose
Nothing to Disclose
Merck, attendance to an advisory board meeting:
Advisory Board
Jazz Pharmaceuticals, collaborating investigator: working on a retrospective study by the company in collaboration with the BMTCTN
merck, attendees of the advisory board meetiing: Advisory Board
Jazz pharmaceuticals, collabrator: working on a retrospective study by the company in collaboration with the BMTCTN
Celgene, speaker activity: Honoraria
Jazz Pharmaceuticals, collaborating investigator: working on a retrospective study by the company in collaboration with the BMTCTN
merck, attendees of the advisory board meetiing: Advisory Board
Jazz pharmaceuticals, collabrator: working on a retrospective study by the company in collaboration with the BMTCTN
Celgene, speaker activity: Honoraria
Nothing to Disclose
Nothing to Disclose
GENENTA Science, Founder, owns equity, chairs the scientific advisory board and is a consultant:
Consultancy
Magenta Therapeutics, Founder, owns equity, is a member of the scientific advisory board: Consultancy
GlaxoSmithKline (GSK), In 2010 SR-Tiget entered into a strategic alliance with GlaxoSmithKline (GSK) for the development up to marketing authorization of hematopoietic stem cell gene therapy for some rare diseases. Whereas SR-Tiget remains responsible for pre-clinical developme: See description above
Magenta Therapeutics, Founder, owns equity, is a member of the scientific advisory board: Consultancy
GlaxoSmithKline (GSK), In 2010 SR-Tiget entered into a strategic alliance with GlaxoSmithKline (GSK) for the development up to marketing authorization of hematopoietic stem cell gene therapy for some rare diseases. Whereas SR-Tiget remains responsible for pre-clinical developme: See description above
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Honoraria:
Consultancy
Actinium Pharmaceuticals, Inc., Clinical Investigator for:
Honoraria
and
Research Funding
Actinium Pharmaceuticals, Inc., Clinical Investigator for: Consultancy , Honoraria and Research Funding
Actinium Pharmaceuticals, Inc., Clinical Investigator for: Consultancy , Honoraria and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, a Gilead Company, membership on Board of Directors or advisory committees:
Advisory Board
,
Consultancy
and
Research Funding
Celgene, membership on Board of Directors or advisory committees: Advisory Board , Consultancy and Research Funding
Merck, membership on Board of Directors or advisory committees: Advisory Board , Consultancy and Research Funding
Cellectis, independent contractor: Research Funding
Poseida, independent contractor: Research Funding
Acerta, independent contractor: Research Funding
Karus, independent contractor: Research Funding
Bristol-Myers-Squib, independent contractor: Research Funding
Novarits, membership on Board of Directors or advisory committees: Advisory Board
Unum Therapeutics, membership on Board of Directors or advisory committees: Advisory Board
Celgene, membership on Board of Directors or advisory committees: Advisory Board , Consultancy and Research Funding
Merck, membership on Board of Directors or advisory committees: Advisory Board , Consultancy and Research Funding
Cellectis, independent contractor: Research Funding
Poseida, independent contractor: Research Funding
Acerta, independent contractor: Research Funding
Karus, independent contractor: Research Funding
Bristol-Myers-Squib, independent contractor: Research Funding
Novarits, membership on Board of Directors or advisory committees: Advisory Board
Unum Therapeutics, membership on Board of Directors or advisory committees: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Scisco Genetics, Technology development:
Salary
Novartis Pharmaceutical, Advisor:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, Employee:
Salary
Nothing to Disclose
Rocket Pharmaceuticals, LTd, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cellectis, Advisor:
Advisory Board
Novartis, speaker buero: Honoraria
Daiichi, speaker buero: Honoraria
Novartis, speaker buero: Honoraria
Daiichi, speaker buero: Honoraria
Nothing to Disclose
Nothing to Disclose
Caelus Pharmaceuticals, Member of Scientific Advisory Board:
Advisory Board
Nothing to Disclose
Kite Pharma, Advisory Board:
Advisory Board
Nkarta, Advisory Board: Advisory Board
Nkarta, Advisory Board: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Windmiltherapheutics, CSO:
Ownership Interest
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, Research and Development Manager:
Salary
Nothing to Disclose
O
Nothing to Disclose
Nothing to Disclose
Juno, Researcher:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Atara Biotherapeutics, other:
Royalty
Atara Biotherapeutics, other: Consultancy and Research Funding
Atara Biotherapeutics, other: Consultancy and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite Pharmacuticals, Consultant:
Advisory Board
Spectrum Pharmaceuticals, Consultant: Advisory Board
Pfizer, Consultant: Advisory Board
Pfizer Pharmaceuticals, Honoraria: Advisory Board
Spectrum Pharmaceuticals, Honoraria: Advisory Board
Kite/Gilead, Honoraria: Advisory Board
Spectrum Pharmaceuticals, Consultant: Advisory Board
Pfizer, Consultant: Advisory Board
Pfizer Pharmaceuticals, Honoraria: Advisory Board
Spectrum Pharmaceuticals, Honoraria: Advisory Board
Kite/Gilead, Honoraria: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cidara Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, NA:
Research Funding
Magenta Therapeutics, Study Investigator: Research Funding
Magenta Therapeutics, Study Investigator: Research Funding
Nothing to Disclose
Lentigen Technology Inc., Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Other, Other:
Intellectual Property Rights
and
Royalty
Nothing to Disclose
Nothing to Disclose
Pfizer, Research Funding and Speakers Bureau:
Honoraria
Novo Nordisk, Research Funding and Speakers Bureau: Honoraria
Grifols, Research Funding: Honoraria
BioMarin, Speakers Bureau: Honoraria
Bioverativ, Research Funding: Honoraria
Shire, Research Funding and Speakers Bureau: Honoraria
Novo Nordisk, Research Funding and Speakers Bureau: Honoraria
Grifols, Research Funding: Honoraria
BioMarin, Speakers Bureau: Honoraria
Bioverativ, Research Funding: Honoraria
Shire, Research Funding and Speakers Bureau: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
P
Novartis, Employment:
Ownership Interest
and
Salary
Viracor IBT, patent owner:
Royalty
Viracor-IBT laboratories, Role patent owner: Royalty
Viracor-IBT laboratories, Role patent owner: Royalty
Nothing to Disclose
Pharmacyclics, an AbbVie Company, .:
Consultancy
Gilead, .: Consultancy
Gilead, .: Consultancy
Gentium/Jazz Pharmaceuticals, Support:
Advisory Board
,
Honoraria
and
speakers bureau
Nothing to Disclose
Merrimack Pharmaceuticals, Spouse is advisory board member:
Advisory Board
and
Ownership Interest
Boston Children's Hospital, Employee: Salary
National Institutes of Health, Researcher: Research Funding
Boston Children's Hospital, Employee: Salary
National Institutes of Health, Researcher: Research Funding
Nothing to Disclose
Takeda Pharmaceutical International, Inc, Co-Investigator:
Research Funding
Nothing to Disclose
Magenta Therapeutics, Scientist:
Intellectual Property Rights
,
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Merck and Pharmacyclics, consultant:
Consultancy
Celgene, Advisory Board: Advisory Board
flagship ventures, novartis, evelo, Jazz, Therakos, Amgen, Merck &co, DKMS medical council, Acute Leukemia Forum, Seres Therapeutics, Juno therapeutics, spouse financial disclosures: spouse consultant/ honoraria
Celgene, Advisory Board: Advisory Board
flagship ventures, novartis, evelo, Jazz, Therakos, Amgen, Merck &co, DKMS medical council, Acute Leukemia Forum, Seres Therapeutics, Juno therapeutics, spouse financial disclosures: spouse consultant/ honoraria
Memorial Sloan Kettering Cancer Center, Principle Investigator:
Intellectual Property Rights
Memorial Sloan Kettering Cancer Center, Principle Investigator/Inventor: Intellectual Property Rights
Memorial Sloan Kettering Cancer Center, Principle Investigator/Inventor: Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Vir Biotechnology, Inc, Senior Vice President:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Aveo, other:
Ownership Interest
BG Medicine, other: Ownership Interest
Biogen, other: Chairman of the Board and Ownership Interest
Exelixis, other: Chairman of the Board and Ownership Interest
Proteostasis, other: Ownership Interest
Regulus, other: Chairman of the Board and Ownership Interest
Evelo, other: Ownership Interest
Apellis, other: Ownership Interest
Leap Therapeutics, other: Ownership Interest
BG Medicine, other: Ownership Interest
Biogen, other: Chairman of the Board and Ownership Interest
Exelixis, other: Chairman of the Board and Ownership Interest
Proteostasis, other: Ownership Interest
Regulus, other: Chairman of the Board and Ownership Interest
Evelo, other: Ownership Interest
Apellis, other: Ownership Interest
Leap Therapeutics, other: Ownership Interest
Merck, Investigator:
Consultancy
and
Research Funding
Chimerix, Investigator: Consultancy and Research Funding
Astellas, Investigator: Consultancy and Research Funding
Clinigen, Investigator: Consultancy
Shire, Investigator: Research Funding
Merck, Investigator: Advisory Board , Consultancy and Research Funding
Clinigen, consultant: Honoraria
Chimerix, Astellas, Merck, Research, Advisor: Grant, Consultancy fees
Shire, Investigator Clinical Trial: Research Support
Clinigen, Advisory Board: Advisory fees
Chimerix, Investigator: Consultancy and Research Funding
Astellas, Investigator: Consultancy and Research Funding
Clinigen, Investigator: Consultancy
Shire, Investigator: Research Funding
Merck, Investigator: Advisory Board , Consultancy and Research Funding
Clinigen, consultant: Honoraria
Chimerix, Astellas, Merck, Research, Advisor: Grant, Consultancy fees
Shire, Investigator Clinical Trial: Research Support
Clinigen, Advisory Board: Advisory fees
Nothing to Disclose
Nothing to Disclose
Incyte Corporation, Employee:
Salary
and
Stock
Nothing to Disclose
Incyte, Research:
Salary
and
stock
Nothing to Disclose
Nothing to Disclose
Kariurs, Inc., Principle Clinical Data Manager:
Salary
Pharmacyclics, Research funding:
Research Funding
MorphoSys, Research funding: Research Funding
Janssen, Research funding: Research Funding
AbbVie, Research funding: Advisory Board and Research Funding
AstraZeneca, Research funding: Advisory Board and Research Funding
Ascentage Pharma, Research funding: Research Funding
MorphoSys, Research funding: Research Funding
Janssen, Research funding: Research Funding
AbbVie, Research funding: Advisory Board and Research Funding
AstraZeneca, Research funding: Advisory Board and Research Funding
Ascentage Pharma, Research funding: Research Funding
Nothing to Disclose
Amgen, None:
Advisory Board
and
Consultancy
Juno Therapeutics, None: Advisory Board , Consultancy and Research Funding
Genentech/Roche, None: Research Funding
Juno Therapeutics, None: Advisory Board , Consultancy and Research Funding
Genentech/Roche, None: Research Funding
NeoImmuneTech, CSO:
Intellectual Property Rights
,
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
BMS, consulting and research funding:
Consultancy
and
Research Funding
Rafael Pharma, consulting: Consultancy
G1 Therapeutics, consulting: Consultancy
Teva, consulting and research funding: Consultancy and Research Funding
Gilead, speakers bureau: Honoraria
Seattle Genetics, speakers bureau and research funding: Honoraria and Research Funding
Takeda, research funding: Research Funding
Rafael Pharma, consulting: Consultancy
G1 Therapeutics, consulting: Consultancy
Teva, consulting and research funding: Consultancy and Research Funding
Gilead, speakers bureau: Honoraria
Seattle Genetics, speakers bureau and research funding: Honoraria and Research Funding
Takeda, research funding: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Chair of a session:
Honoraria
Pfizer, Advisory Board: Advisory Board
Medigene, Consultant: Consultancy
Celgene, Member: Honoraria
Pfizer, Advisory Board: Advisory Board
Medigene, Consultant: Consultancy
Celgene, Member: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, Speaker Bureau:
Honoraria
Jannsen, Spekaer Bureau: Honoraria
Jannsen, Spekaer Bureau: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Stem Line, Advisory Board:
Advisory Board
Celgene, none:
Advisory Board
Janssen, none: Advisory Board
Janssen, none: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, employee:
Ownership Interest
and
Salary
Magenta Therapeutics, employee: Intellectual Property Rights , Ownership Interest and Salary
Magenta Therapeutics, employee: Intellectual Property Rights , Ownership Interest and Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seres Therapeutics, collaborator:
Research Funding
and
Royalty
Gamida Cell, employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Exec VP of R&D/CMO:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Merck, Consultant:
Advisory Board
Incyte, Ad Board: Advisory Board and Research Funding
Novartis, Ad Board: Advisory Board
Abbvie, Ad Board: Advisory Board
MolMed, Member, Scientific Advisory Board: Advisory Board
Nektar Therapeutics, Ad Board: Advisory Board
NexImmune, Member, Scientific Advisory Board: Advisory Board
Servier, Member, DSMB: Honoraria
Abbvie, Honoraria: Advisory Board
Bellicum, Honoraria: Advisory Board
Incyte, Honoraria: Advisory Board
Nektar Therapeutics, Honoraria: Advisory Board
Novartis, Honoraria: Advisory Board
Merck, Honoraria: Consultancy
Medigene, Honoraria: Member, DSMB
Servier, Honoraria: Member, DSMB
Incyte, Research Support: Research Funding
Miltenyi, Research Support: Research Funding
MolMed, Honoraria: Advisory Board
NexImmune, Honoraria: Advisory Board
Medigene, Honoraria: member, DSMB
Miltenyi, Research Funding: Research Funding
MolMed, Member, Scientific Advisory Board: Honoraria
NexImmune, Member, Scientific Advisory Board: Honoraria
Abbvie, Ad hoc Advisory Board: Honoraria
Bellicum, Ad hoc Advisory Board: Honoraria
Incyte Corporation, Ad hoc Advisory Board: Honoraria
Nektar Therapeutics, Ad hoc Advisory Board: Honoraria
Novartis, Ad hoc Advisory Board: Honoraria
Merck, Consulting: Honoraria
Medigene, Member, DSMB: Honoraria
Incyte, Clinical trial: Research Funding
Miltenyi, Clinical trial: Research Funding
Incyte, Ad Board: Advisory Board and Research Funding
Novartis, Ad Board: Advisory Board
Abbvie, Ad Board: Advisory Board
MolMed, Member, Scientific Advisory Board: Advisory Board
Nektar Therapeutics, Ad Board: Advisory Board
NexImmune, Member, Scientific Advisory Board: Advisory Board
Servier, Member, DSMB: Honoraria
Abbvie, Honoraria: Advisory Board
Bellicum, Honoraria: Advisory Board
Incyte, Honoraria: Advisory Board
Nektar Therapeutics, Honoraria: Advisory Board
Novartis, Honoraria: Advisory Board
Merck, Honoraria: Consultancy
Medigene, Honoraria: Member, DSMB
Servier, Honoraria: Member, DSMB
Incyte, Research Support: Research Funding
Miltenyi, Research Support: Research Funding
MolMed, Honoraria: Advisory Board
NexImmune, Honoraria: Advisory Board
Medigene, Honoraria: member, DSMB
Miltenyi, Research Funding: Research Funding
MolMed, Member, Scientific Advisory Board: Honoraria
NexImmune, Member, Scientific Advisory Board: Honoraria
Abbvie, Ad hoc Advisory Board: Honoraria
Bellicum, Ad hoc Advisory Board: Honoraria
Incyte Corporation, Ad hoc Advisory Board: Honoraria
Nektar Therapeutics, Ad hoc Advisory Board: Honoraria
Novartis, Ad hoc Advisory Board: Honoraria
Merck, Consulting: Honoraria
Medigene, Member, DSMB: Honoraria
Incyte, Clinical trial: Research Funding
Miltenyi, Clinical trial: Research Funding
Nothing to Disclose
Hospital Israelita Albert Einstein, MD:
MD
Nothing to Disclose
Scisco Genetics, Inc, Clinical Lab Director:
Consultancy
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Spectrum Pharmaceuticals, recipient of research funding:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, Inc., Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen:
Consultancy
and
Speaker Bureau
Abbvie: Consultancy and Speaker Bureau
Abbvie: Consultancy and Speaker Bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nohla Therapeutics, other:
research support
Angiocrine Bioscience, other: Research Funding
Nohla Therapeutics, other: Clinical trial regulatory oversight
Angiocrine Bioscience, other: Research Funding
Nohla Therapeutics, other: Clinical trial regulatory oversight
Guidepoint, Consultant:
Consultancy
Gerson and Lehrman Group, Consultant: Consultancy
Gerson and Lehrman Group, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Genentech, Spouse employment:
Salary
and
Stock
Incyte, Honoraria: Advisory Board
Kite/Gilead, Honoraria: Advisory Board
Novartis, Other: Financial Benefit and/or patents and Royalty
Novartis, Honoraria: Advisory Board
Novartis, Research Support: Research Funding
Incyte, Honoraria: Advisory Board
Kite/Gilead, Honoraria: Advisory Board
Novartis, Other: Financial Benefit and/or patents and Royalty
Novartis, Honoraria: Advisory Board
Novartis, Research Support: Research Funding
Agios, Speaker:
Honoraria
Novartis, Consultant: Consultancy
Cerus, Speaker: Honoraria
Novartis, Consultant: Consultancy
Cerus, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Atara Biotherapeutics, Investigator:
Research Funding
Mesoblast, Investigator: Research Funding
Mesoblast, Investigator: Research Funding
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, Education:
Education
Adaptive, Advisory Board: Advisory Board
Novartis, Member: Advisory Board
CSL Behring, Advisory Board: Advisory Board
Novartis, Advisory Board: Consultancy
Novartis, Consultant/Speaker: Consultancy
Adaptive, Advisory Board: Advisory Board
Novartis, Member: Advisory Board
CSL Behring, Advisory Board: Advisory Board
Novartis, Advisory Board: Consultancy
Novartis, Consultant/Speaker: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Scisco Genetics Inc, Director in training:
Advisory Board
Q
Servier, External Partner:
Research Funding
Bellicum, External Partner: Research Funding
Autolus, External Partner: Equity Ownership
Orchard, External Partner: Equity Ownership
Bellicum, External Partner: Research Funding
Autolus, External Partner: Equity Ownership
Orchard, External Partner: Equity Ownership
Nothing to Disclose
Novartis, advisory board:
professional medical writing assistance
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
R
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Collaborator:
Research Funding
Nothing to Disclose
Magenta Therapeutics, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Takeda Oncology, Speakers Bureau/consultancy:
Advisory Board
and
Consultancy
Amgen, Consultancy: Advisory Board
Amgen, Consultancy: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Ad board consultant:
Consultancy
Celgene, Ad board consultant: Consultancy
Tessa Therapeutics, Grantee: Research Funding
Celgene, Ad board consultant: Consultancy
Tessa Therapeutics, Grantee: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Incyte, Consultancy:
Consultancy
Equillium, Consultancy: Consultancy
Equillium, Consultancy: Consultancy
GSK, Speaker:
Honoraria
Takeda, Speaker: Honoraria
Cynata, Speaker: Honoraria
Pfizer, Speaker: Honoraria
Spark, Speaker: Honoraria
Novartis, Speaker: Honoraria
Celgene, Speaker: Honoraria
bluebird bio, Speaker: Honoraria
Genea, Director of Pathology: Ownership Interest
Rarecyte, Consultant: Consultancy and Stocks in lieu
Imago, Consultant: Consultancy
Australian Government, Chair of Gene Technology Technical Advisory; past Chair of Advisory Committee on Biologics: Advisory Board
Cure the Future Foundation, Board of Directors: Board of Directors
FSHD Global Research Foundation, Past board member, current scientific patron: Board of Directors; scientific patron
Australian Government, Chair of Gene Technology Technical Advisory; past Chair of Advisory Committee on Biologics: Advisory Board and Chair; Past Chair
Imago Biosciences, Consultant: Consultancy
bluebird bio, Inc., Speaker and Investigator: Clinical Trials and Honoraria
Novartis, Consultant and Speaker: Consultancy and Honoraria
Spark, Consultant and Speaker: Consultancy and Honoraria
International Society for Cellular Therapy, Board member: board member
Abbvie, Speaker: Speakers Bureau
Cynata, Consultant and Speaker: Consultancy and Honoraria
Gilead, Speaker: Honoraria
Takeda, Speaker: Honoraria
Cynata, Speaker: Honoraria
Pfizer, Speaker: Honoraria
Spark, Speaker: Honoraria
Novartis, Speaker: Honoraria
Celgene, Speaker: Honoraria
bluebird bio, Speaker: Honoraria
Genea, Director of Pathology: Ownership Interest
Rarecyte, Consultant: Consultancy and Stocks in lieu
Imago, Consultant: Consultancy
Australian Government, Chair of Gene Technology Technical Advisory; past Chair of Advisory Committee on Biologics: Advisory Board
Cure the Future Foundation, Board of Directors: Board of Directors
FSHD Global Research Foundation, Past board member, current scientific patron: Board of Directors; scientific patron
Australian Government, Chair of Gene Technology Technical Advisory; past Chair of Advisory Committee on Biologics: Advisory Board and Chair; Past Chair
Imago Biosciences, Consultant: Consultancy
bluebird bio, Inc., Speaker and Investigator: Clinical Trials and Honoraria
Novartis, Consultant and Speaker: Consultancy and Honoraria
Spark, Consultant and Speaker: Consultancy and Honoraria
International Society for Cellular Therapy, Board member: board member
Abbvie, Speaker: Speakers Bureau
Cynata, Consultant and Speaker: Consultancy and Honoraria
Gilead, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seattle Genetics, independent contractor:
Research Funding
BMS, none:
Advisory Board
and
Research Funding
Gilead, none: Honoraria
Genentech, none: Advisory Board and Research Funding
AbbVie, none: Advisory Board
Gilead, none: Honoraria
Genentech, none: Advisory Board and Research Funding
AbbVie, none: Advisory Board
Nothing to Disclose
Actinium Pharmaceuticals, Inc., VP Clinical Development:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Affimed, Research:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead, Consultant:
Consultancy
BMS, Consultant: Consultancy
Pfizer, Consultant: Consultancy
Atara, Consultant: Consultancy
BMS, Consultant: Consultancy
Pfizer, Consultant: Consultancy
Atara, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nohla, Ad hoc advisotry board:
Advisory Board
Kaleido, Ad hoc advisory board: Advisory Board
AbbVie, None: Research Funding
Kaleido, Ad hoc advisory board: Advisory Board
AbbVie, None: Research Funding
Onkimmune, SAB:
Consultancy
Kiadis Pharma, IDMC: Consultancy
Serono Merck, SAB: Consultancy
Kiadis Pharma, IDMC: Consultancy
Serono Merck, SAB: Consultancy
Altor BioScience Corporation, SVP, R&D:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, Inc., Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Support:
Advisory Board
and
Research Funding
Jazz Pharmaceuticals, Support: Advisory Board , Consultancy and Research Funding
Jazz Pharmaceuticals, Support: Advisory Board , Consultancy and Research Funding
Nothing to Disclose
Nothing to Disclose
Nohla, Adaptive Biotechnologies, Consultant:
Consulting Fee
Juno Therapeutics, Research Funding: Intellectual Property Rights , Ownership Interest , Research Funding and Royalty
Cell Medica, Advisory board member: Advisory Board
Adaptive Biotechnologies, Consultant: Consultancy
NOHLA, Consultant: Consultancy
Juno Therapeutics, Research Funding: Intellectual Property Rights , Ownership Interest , Research Funding and Royalty
Cell Medica, Advisory board member: Advisory Board
Adaptive Biotechnologies, Consultant: Consultancy
NOHLA, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Kite/Gilead, Research Support:
Research Funding
Verastem, Honoraria: Advisory Board
Bayer, Honoraria: Advisory Board and Speaker
Kite/Gilead, Honoraria: Advisory Board and Speaker
Novartis, Research Support: Research Funding
Celgene/Juno, Research Support: Research Funding
Verastem, Honoraria: Advisory Board
Bayer, Honoraria: Advisory Board and Speaker
Kite/Gilead, Honoraria: Advisory Board and Speaker
Novartis, Research Support: Research Funding
Celgene/Juno, Research Support: Research Funding
Nothing to Disclose
Novartis, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, Consultant:
Advisory Board
and
Consultancy
Celgene, Consultant: Advisory Board , Consultancy and Travel accommodations/expenses
Pfizer, Consultant: Consultancy and Research Funding
Novartis, Consultant: Consultancy , Research Funding and Travel accommodations/expenses
ARIAD Pharmaceutical, Speakers bureau: Advisory Board
Astellas Pharma, Research: Research Funding
Bristol-Myers Squibb, Research: Research Funding
NS Pharma, NS Pharma: Research Funding
Celgene, Consultant: Advisory Board , Consultancy and Travel accommodations/expenses
Pfizer, Consultant: Consultancy and Research Funding
Novartis, Consultant: Consultancy , Research Funding and Travel accommodations/expenses
ARIAD Pharmaceutical, Speakers bureau: Advisory Board
Astellas Pharma, Research: Research Funding
Bristol-Myers Squibb, Research: Research Funding
NS Pharma, NS Pharma: Research Funding
Avrobio, Consultant:
DSMC member
Draper Labs, Consultant: Consultancy
Amgen, Consultant: Advisory Board
Delinia-Celgene, Consultant: Advisory Board
Kite Pharma, none: Research Funding
Nektar, none: Research Funding
Roche, none: Research Funding
Celgene, Advisory Board: Consultancy
LifeVault Bio, Advisory Board: Consultancy
AvroBio, Advisory Board: Consultancy
TScan Therapeutics, Advisory Board: Consultancy
Draper Labs, Consultant: Consultancy
Amgen, Consultant: Advisory Board
Delinia-Celgene, Consultant: Advisory Board
Kite Pharma, none: Research Funding
Nektar, none: Research Funding
Roche, none: Research Funding
Celgene, Advisory Board: Consultancy
LifeVault Bio, Advisory Board: Consultancy
AvroBio, Advisory Board: Consultancy
TScan Therapeutics, Advisory Board: Consultancy
Nothing to Disclose
Nothing to Disclose
Novartis, Advisor:
Advisory Board
,
Consultancy
and
Travel expenses for medical congress, talks at industrial symposia
JazzPharma, Advisor: Advisory Board , Consultancy and Travel expenses for medical congress, talks at industrial symposium
Baxalta/Shire/Servier, Advisor: Advisory Board , Consultancy and Travel expenses for medical congress, talks at industrial symposium
ErytechPharma, Advisor: Advisory Board and Travel expenses for medical congress, talks at industrial symposium
Amgen, Advisor: Advisory Board
Astellas, Advisor: Research Funding and Travel Expenses
JazzPharma, Advisor: Advisory Board , Consultancy and Travel expenses for medical congress, talks at industrial symposium
Baxalta/Shire/Servier, Advisor: Advisory Board , Consultancy and Travel expenses for medical congress, talks at industrial symposium
ErytechPharma, Advisor: Advisory Board and Travel expenses for medical congress, talks at industrial symposium
Amgen, Advisor: Advisory Board
Astellas, Advisor: Research Funding and Travel Expenses
Nothing to Disclose
Juno Therapeutics:
Consultancy
and
Financial Benefit and/or patents
Fate Therapeutics: Consultancy and Financial Benefit and/or patents
FloDesign: Financial Benefit and/or patents
Fate Therapeutics: Consultancy and Financial Benefit and/or patents
FloDesign: Financial Benefit and/or patents
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, Employment:
Ownership Interest
,
Salary
and
Travel/Accomodations/Expenses
Viracyte, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
CRISPR Therapeutics, Clinical trial steering committee member:
Honoraria
Incyte, GVHD advisory board meeting: Honoraria
Incyte, GVHD advisory board meeting: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracyte, Co-founder:
Advisory Board
and
Ownership Interest
Marker Therapeutics, Co-founder: Advisory Board and Ownership Interest
Tessa Therapeutics, None: Research Funding
Cell Medica, None: Intellectual Property Rights
Marker Therapeutics, Co-founder: Advisory Board and Ownership Interest
Tessa Therapeutics, None: Research Funding
Cell Medica, None: Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
School of Dentistry University of Sao Paulo, biologist:
biologist
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, Employment:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kiadis Pharma:
Travel support
University of Montreal: Author on patent
University of Montreal: Author on patent
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cidara, Contracted Researcher:
Research Funding
Nothing to Disclose
KITE a Gilead Company, Member - Allied Health Steering Committe:
Committe Member
KITE a Gilead Company, Committe Member: Committee Member
KITE a Gilead Company, Committe Member: Committee Member
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AbbVie, Equity owner:
Ownership Interest
University of Rochester, Patent and royalty owner: Intellectual Property Rights and Royalty
University of Rochester, Patent and royalty owner: Intellectual Property Rights and Royalty
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Ownership Interest
and
Salary
Jazz, Employee: Ownership Interest and Salary
Jazz, Employee: Ownership Interest and Salary
Nothing to Disclose
S
BMS, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Berkeley Lights:
Advisory Board
Atara Biotheraputics: Financial Benefit and/or patents
Fate Therapeutics: Financial Benefit and/or patents
Juno Therapeutics: Financial Benefit and/or patents
Atara Biotheraputics: Financial Benefit and/or patents
Fate Therapeutics: Financial Benefit and/or patents
Juno Therapeutics: Financial Benefit and/or patents
Nothing to Disclose
Kite, None:
Advisory Board
Bayer, None: Advisory Board and Honoraria
Bayer, None: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Humanigen, Employee:
Employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Advisory Board
,
Consultancy
and
Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celegene, member:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Cidara Therapeutics, Employee:
Ownership Interest
and
Salary
Kiadis Pharma, Chief Medical Officer:
Salary
Kiadis Pharma, participant:
Advisory Board
Actinium, member: Advisory Board
OncoResponse, spouse of consultant: Financial Benefit and/or patents
AnaptysBio, Souse of consultant: Financial Benefit and/or patents
Bellicum, site investigator: Research Funding
Actinium, member: Advisory Board
OncoResponse, spouse of consultant: Financial Benefit and/or patents
AnaptysBio, Souse of consultant: Financial Benefit and/or patents
Bellicum, site investigator: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Juno Therapeutics/Celgene, None:
Advisory Board
and
Consultancy
Kite Pharma/Gilead, None: Advisory Board and Consultancy
Novartis, None: Advisory Board and Consultancy
Kite Pharma/Gilead, None: Advisory Board and Consultancy
Novartis, None: Advisory Board and Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
ASBMT, Director of lab sciences:
voting member board of directors
Gilead, grant recipient: Consultancy and Research Funding
Pharmacyclics, served 2x on advisory board: Advisory Board
Gilead, grant recipient: Consultancy and Research Funding
Pharmacyclics, served 2x on advisory board: Advisory Board
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merk Honorarium, Committe member:
Advisory Board
Nothing to Disclose
Merck, Subinvestigator:
Research Funding
Juno Therapeutics, Consultant:
Consultancy
Sanofi-Genzyme, Consultant: Consultancy
Spectrum Pharmceuticals, Consultant: Consultancy
Novartis, Consultant: Consultancy
Precision Biosciences, Consultant: Consultancy
Kite, a Gilead Company, Consultant: Consultancy
June Therapeutics, other: Research Funding
Sanofi-Genzyme, other: Research Funding
Sanofi-Genzyme, Consultant: Consultancy
Spectrum Pharmceuticals, Consultant: Consultancy
Novartis, Consultant: Consultancy
Precision Biosciences, Consultant: Consultancy
Kite, a Gilead Company, Consultant: Consultancy
June Therapeutics, other: Research Funding
Sanofi-Genzyme, other: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Magenta Therapeutics, Scientist:
Ownership Interest
and
Salary
Viracor-Eurofins, Employee:
Salary
Nothing to Disclose
Magenta Therapeutics, Director:
Consultancy
,
Ownership Interest
and
scientific advisory board
Fate Therapeutics, Consultant: Consultancy , Ownership Interest and scientific advisory board
Agios Pharmaceuticals, Director: Shareholder
Bone Therapeutics, Consultant: scientific advisory board
Fate Therapeutics, Consultant: Consultancy , Ownership Interest and scientific advisory board
Agios Pharmaceuticals, Director: Shareholder
Bone Therapeutics, Consultant: scientific advisory board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Janssen Global Commercial Strategy Organization, Employee:
Employee
Nothing to Disclose
Nothing to Disclose
medac GmbH, Investigator:
travel grants for scientific meetings
Nothing to Disclose
Nothing to Disclose
MolMed, advisory board:
Advisory Board
and
lecture fees
Janssen, advisory board: Advisory Board and lecture fees
Gilead, advisory board: Advisory Board and lecture fees
Abbvie, advisory board: Advisory Board , lecture fees and Research Funding
Novartis, advisory board: Advisory Board , lecture fees and Research Funding
Roche, advisory board: Advisory Board and lecture fees
Janssen, advisory board: Advisory Board and lecture fees
Gilead, advisory board: Advisory Board and lecture fees
Abbvie, advisory board: Advisory Board , lecture fees and Research Funding
Novartis, advisory board: Advisory Board , lecture fees and Research Funding
Roche, advisory board: Advisory Board and lecture fees
Nothing to Disclose
Merck and Co, Inc, Collaborator:
Research Funding
Genocea, Independent Contractor: Research Funding
Genocea, Independent Contractor: Research Funding
Astellas Pharm, Board of Directors/Advisory Committee:
Advisory Board
and
Research Funding
Bluebird Bio, Research: Research Funding
Bluebird Bio, Research: Research Funding
bluebird bio, Inc., Funding recipient:
Research Funding
Astellas Pharma, Board member: Advisory Board and Research Funding
bluebird bio, Funding recipient: Research Funding
Astellas Pharma, Board member: Advisory Board and Research Funding
bluebird bio, Funding recipient: Research Funding
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, employee:
Salary
Amgen, MD:
Advisory Board
and
Speakers bureau
Celgene, MD: Advisory Board and Speakers bureau
Takeda, MD: Advisory Board and Speakers bureau
Janssen, MD: Advisory Board and Speakers bureau
Abbvie, MD: Speakers bureau
BMS, MD: Advisory Board
Bayer, MD: Advisory Board
Adaptive, MD: Advisory Board
Oncopeptides, MD: Advisory Board
Celgene, MD: Advisory Board and Speakers bureau
Takeda, MD: Advisory Board and Speakers bureau
Janssen, MD: Advisory Board and Speakers bureau
Abbvie, MD: Speakers bureau
BMS, MD: Advisory Board
Bayer, MD: Advisory Board
Adaptive, MD: Advisory Board
Oncopeptides, MD: Advisory Board
Jazz Pharma, Advisor, Speaker:
Advisory Board
and
Honoraria
Neovii, Speaker: Honoraria and Travel grand
Novartis, Speaker: Honoraria and Travel grand
Neovii, Speaker: Honoraria and Travel grand
Novartis, Speaker: Honoraria and Travel grand
Nothing to Disclose
Nothing to Disclose
GeneWerk GmbH, Employee:
Salary
German Cancer Research Center, Employee: Salary
bluebird bio, Inc., Consultant: Consultancy
German Cancer Research Center, Employee: Salary
bluebird bio, Inc., Consultant: Consultancy
Lophius Biosciences, Employment:
Salary
Nothing to Disclose
Juno, Ad Board:
Consultancy
Novartis, Ad Board: Consultancy
Kite, Ad Board: Consultancy
Novartis, Ad Board: Consultancy
Kite, Ad Board: Consultancy
Nothing to Disclose
Nothing to Disclose
Lentigen Technology Inc., Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
FlatIron, Consulting:
Consultancy
Takeda, Speaking: Speakers bureau
Merck, Speaking: Speakers bureau
Sanofi/Genzyme, Consulting: Advisory Board and Honoraria
Pfizer, Consulting: Advisory Board and Honoraria
Amgen, Consulting: Advisory Board and Honoraria
Incyte Corporation, Consulting: Advisory Board and Honoraria
Takeda, Speaking: Speakers bureau
Merck, Speaking: Speakers bureau
Sanofi/Genzyme, Consulting: Advisory Board and Honoraria
Pfizer, Consulting: Advisory Board and Honoraria
Amgen, Consulting: Advisory Board and Honoraria
Incyte Corporation, Consulting: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Kadmon Corporation, LLC, Employee:
Salary
Amgen, Consultant:
Consultancy
Celgene, Consultant: Consultancy
Shire, Consultant: Consultancy
Teva, Consultant: Consultancy
Novartis, Consultant: Consultancy
Otsuka, Consultant: Consultancy
Jazz, Consultant: Consultancy
Pfizer, Consultant: Consultancy
Celgene, Consultant: Consultancy
Shire, Consultant: Consultancy
Teva, Consultant: Consultancy
Novartis, Consultant: Consultancy
Otsuka, Consultant: Consultancy
Jazz, Consultant: Consultancy
Pfizer, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Consultancy
and
Honoraria
Celgene, NA: Advisory Board , Consultancy and Research Funding
Dava Oncology, NA: Honoraria
Genentech, NA: Advisory Board , Consultancy and Research Funding
Gilead, NA: Advisory Board and Consultancy
Merck, NA: Advisory Board and Research Funding
Nordic Nanovector, NA: Advisory Board and Research Funding
Pfizer, NA: Advisory Board
OncoViRx, NA: Advisory Board
Pharmacyclics, NA: Advisory Board
OncLive, NA: Presentation
i3Health, NA: Presentation
Celgene, NA: Advisory Board , Consultancy and Research Funding
Dava Oncology, NA: Honoraria
Genentech, NA: Advisory Board , Consultancy and Research Funding
Gilead, NA: Advisory Board and Consultancy
Merck, NA: Advisory Board and Research Funding
Nordic Nanovector, NA: Advisory Board and Research Funding
Pfizer, NA: Advisory Board
OncoViRx, NA: Advisory Board
Pharmacyclics, NA: Advisory Board
OncLive, NA: Presentation
i3Health, NA: Presentation
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Angiocrine Bioscience, Inc., Consultant:
Consultancy
McKinsey & Company, Ad hoc consultant: Consultancy
McKinsey & Company, Ad hoc consultant: Consultancy
Incyte, Consultant:
Consultancy
and
Honoraria
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Agios, Consultant: Advisory Board , Consultancy and Honoraria
Novartis, Consultant: Consultancy and Honoraria
Celgene, Consultancy: Consultancy
Celgene, Research: Research Funding
Agios, Consultancy: Consultancy
Alexion, Consultancy: Consultancy
Novartis, Research: Research Funding
Celgene, Consultant: Advisory Board , Consultancy and Honoraria
Agios, Consultant: Advisory Board , Consultancy and Honoraria
Novartis, Consultant: Consultancy and Honoraria
Celgene, Consultancy: Consultancy
Celgene, Research: Research Funding
Agios, Consultancy: Consultancy
Alexion, Consultancy: Consultancy
Novartis, Research: Research Funding
Nothing to Disclose
Nothing to Disclose
Sarah Cannon, Sr Director Outcomes Research:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi-Genzyme, member of Speakers Bureau:
Honoraria
Jazz Pharmaceuticals, participant on advisory board: Advisory Board and Honoraria
Bristol Myers Squibb, participant on advisory board: Advisory Board and Honoraria
Jazz Pharmaceuticals, participant on advisory board: Advisory Board and Honoraria
Bristol Myers Squibb, participant on advisory board: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kiadis Pharma:
Financial Benefit and/or patents
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kariurs, Inc., Sr. Clinical Research Associate:
Salary
Nothing to Disclose
Nothing to Disclose
Janssen Global Commercial Strategy Organization, Employee:
Employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Merck, research funding:
Research Funding
GeneCentric, Consultant: Consultancy
Merck Inc., Investigator: Research Funding
Glaxo Smith Kline, Investigator: Research Funding
PIQUE, Advisor: Consultancy
GeneCentric, Consultant: Consultancy
Merck Inc., Investigator: Research Funding
Glaxo Smith Kline, Investigator: Research Funding
PIQUE, Advisor: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Rocket Pharma, Consulting:
Consultancy
and
Royalty
Nothing to Disclose
Nothing to Disclose
Genentech, Consultant:
Consultancy
and
Research Funding
Pharmacyclics, Research Funding: Research Funding
Gilead, Research Funding: Research Funding
Acerta, Research Funding: Research Funding
TG Therapeutics, Research Funding: Research Funding
Mustang, Research Funding: Research Funding
Beigene, Research Funding: Research Funding
Qilu Puget Sound Biotherapeutics, Consultant: Consultancy
Abbvie, Consultant: Consultancy
AstraZeneca, Consultant: Consultancy
Verastem, Consultancy: Consultancy
Pharmacyclics, Research Funding: Research Funding
Gilead, Research Funding: Research Funding
Acerta, Research Funding: Research Funding
TG Therapeutics, Research Funding: Research Funding
Mustang, Research Funding: Research Funding
Beigene, Research Funding: Research Funding
Qilu Puget Sound Biotherapeutics, Consultant: Consultancy
Abbvie, Consultant: Consultancy
AstraZeneca, Consultant: Consultancy
Verastem, Consultancy: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen, Investigator:
Research Funding
Amgen, Investigator: Research Funding
Amgen, none: Research Funding
Janssen, none: Research Funding
Amgen, Investigator: Research Funding
Amgen, none: Research Funding
Janssen, none: Research Funding
Nothing to Disclose
Actinium Pharmaceuticals, Inc., consultant to:
Consultancy
Actinium, Outside Consultant: Consultancy
Novartis, Outside Consultant: Consultancy
Miltenyi, Outside Consultant: Consultancy
Bellicum, Outside Consultant: Consultancy
Nohla, Outside Consultant: Consultancy
Actinium, Outside Consultant: Consultancy
Novartis, Outside Consultant: Consultancy
Miltenyi, Outside Consultant: Consultancy
Bellicum, Outside Consultant: Consultancy
Nohla, Outside Consultant: Consultancy
Nothing to Disclose
Celgene, PI:
Research Funding
Bluebird, PI: Research Funding
Janssen, PI: Research Funding
Sutro, PI: Research Funding
Kite, consultant: Consultancy
BMS, consultant: Consultancy
Teneobio, consultant: Consultancy
Amgen, consultant: Consultancy
Indapta, consultant: Advisory Board
Bluebird, PI: Research Funding
Janssen, PI: Research Funding
Sutro, PI: Research Funding
Kite, consultant: Consultancy
BMS, consultant: Consultancy
Teneobio, consultant: Consultancy
Amgen, consultant: Consultancy
Indapta, consultant: Advisory Board
Nothing to Disclose
Lentigen, A Miltenyi Biotec Company, Not employed:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Baston Biologics Company, Membership on an entity's Board of Directors or advisory committees:
Advisory Board
JSK Therapeutics, Employment, Equity Ownership and Membership on an entity's Board of Directors or advisory committees: Advisory Board , Ownership Interest and Salary
Lone Star Biotherapies, Equity Ownership: Ownership Interest
Pfizer, Consultant: Consultancy
JSK Therapeutics, Employment, Equity Ownership and Membership on an entity's Board of Directors or advisory committees: Advisory Board , Ownership Interest and Salary
Lone Star Biotherapies, Equity Ownership: Ownership Interest
Pfizer, Consultant: Consultancy
Nothing to Disclose
Mallinckrodt Pharmaceuticals, Health Economics and Outcomes Research:
Salary
Magenta Therapeutics, Study Staff:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Sanofi, speaker:
Honoraria
Millenium, speaker: Honoraria
Sanofi, Speaker/Advisor: Honoraria
Millennium, Kite, Speaker: Honoraria
Millenium, speaker: Honoraria
Sanofi, Speaker/Advisor: Honoraria
Millennium, Kite, Speaker: Honoraria
Nothing to Disclose
Nothing to Disclose
Nursing and Patient Care Innovations, LLC, Equity owner:
Ownership Interest
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Zhejiang DTRM Biopharma LLC, .:
Clinical Operations Director
Nothing to Disclose
Janssen:
Research Funding
Incyte Corp: Research Funding
Incyte Corp: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, Inc., Employee:
Ownership Interest
and
Salary
Viracor Eurofins Clinical Diagnostics, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Juno Therapeutics, consulting:
steering committee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, MD:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Cynata Therapeutics Limited, Consultant and shareholder:
Consultancy
and
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Scisco Genetics, Inc, Consultant:
Consultancy
Amgen, PI:
Research Funding
Jazz, PI: Research Funding
Jazz, PI: Research Funding
Nothing to Disclose
Nothing to Disclose
Celgene, None:
Consultancy
,
Intellectual Property Rights
,
Research Funding
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, NA:
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Ansun Biopharma, Investigator:
Research grant
Nothing to Disclose
ALEXION, Consultant:
Consultancy
NOVARTIS, Speaker bureau: Advisory Board
THERAKOS, Speaker Bureau: Honoraria
INCYTE, Speaker: Honoraria
ELASYS, Advisor: Consultancy
NOVARTIS, Speaker bureau: Advisory Board
THERAKOS, Speaker Bureau: Honoraria
INCYTE, Speaker: Honoraria
ELASYS, Advisor: Consultancy
Hospital Israelita Albert Einstein, nurse:
nurse
GSK, consultant:
Consultancy
NMDP, consultant: Consultancy
Kiadis, management board: Advisory Board
Juno, consultant: Consultancy
Merck, consultant: Consultancy
Gilead, consultant: Consultancy
Juno, Consultant: Consultancy
Gilead, Consultant: Consultancy
Kidias, management board: Advisory Board
NMDP, consultant: Consultancy
Kiadis, management board: Advisory Board
Juno, consultant: Consultancy
Merck, consultant: Consultancy
Gilead, consultant: Consultancy
Juno, Consultant: Consultancy
Gilead, Consultant: Consultancy
Kidias, management board: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Shire, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Crispr Therapeutics, Inc., Consultant:
Consultancy
BioLineRx Ltd, VP of R&D:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Specialised Therapeutics Australia, MD:
Consultancy
Takeda, MD: Honoraria , Research Funding and Speakerâs bureau
Celgene, MD: Honoraria , Research Funding and Speakerâs bureau
Janssen, MD: Honoraria , Research Funding and Speakerâs bureau
Amgen, MD: Honoraria
GSK, MD: Research Funding
Takeda, MD: Honoraria , Research Funding and Speakerâs bureau
Celgene, MD: Honoraria , Research Funding and Speakerâs bureau
Janssen, MD: Honoraria , Research Funding and Speakerâs bureau
Amgen, MD: Honoraria
GSK, MD: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
takeda, consultant:
Consultancy
amgen, consultant: Consultancy
celgene, consultant: Consultancy
sanofi, consultant: Consultancy
janssen, consultant: Consultancy
Celgene, None: Consultancy
Takeda, None: Consultancy
GSK, External advisory: Research Funding
amgen, consultant: Consultancy
celgene, consultant: Consultancy
sanofi, consultant: Consultancy
janssen, consultant: Consultancy
Celgene, None: Consultancy
Takeda, None: Consultancy
GSK, External advisory: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Washington University in St. Louis, Employee:
Intellectual Property Rights
RiverVest, Consultant: Consultancy
Kinetic River, Consultant: Consultancy
RiverVest, Consultant: Consultancy
Kinetic River, Consultant: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Advisor:
Advisory Board
Nothing to Disclose
Nothing to Disclose
Amgen Inc., Speaker:
Speakers bureau
Celgene, Speaker: Speakers bureau
Celgene, Speaker: Speakers bureau
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen Inc., Celgene, Roche, Seattle Genetics, research:
Research Funding
Amgen Inc., BMS, Celgene, Takeda, Roche, Seattle Genetics, Janssen, Ono, consultancy: Consultancy
Amgen Inc., BMS, Celgene, Takeda, Roche, Seattle Genetics, Janssen, Ono, consultancy: Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Fate Therapeutics, Chief Medical Officer:
Employee of Fate Therapeutics
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceutical, consulting:
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
GSK, External advisor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Kite, Employment:
Salary
Shire, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Seres Therapeutics, Collaborator:
Research Funding
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, MD:
Salary
Atara Biotherapeutics, Investigator:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Sr VP of Research:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz, speakers bureau:
Consultancy
and
Honoraria
BMS, investigator initiated trial: Research Funding
Jazz Pharmaceuticals, Speaker Bureau: Honoraria
BMS, investigator initiated trial: Research Funding
Jazz Pharmaceuticals, Speaker Bureau: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
T
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, NA:
Honoraria
Nothing to Disclose
Nothing to Disclose
Janssen, Employee:
Spouse receives salary.
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
bluebird bio, Inc., employee:
Ownership Interest
and
Salary
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Ph.D:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
MSD, NA:
Consultancy
,
Honoraria
and
Research Funding
Takeda, NA: Consultancy and Research Funding
Janssen, NA: Honoraria and Research Funding
Kyowa-Kirin, NA: Consultancy , Honoraria and Research Funding
Novartis, NA: Consultancy , Honoraria and Research Funding
Celgene, NA: Honoraria
Chugai, NA: Honoraria and Research Funding
Pfizer, NA: Honoraria and Research Funding
Bristol-meyers squibb, NA: Honoraria and Research Funding
Dainippon-Sumitomo, NA: Honoraria
Takeda, NA: Consultancy and Research Funding
Janssen, NA: Honoraria and Research Funding
Kyowa-Kirin, NA: Consultancy , Honoraria and Research Funding
Novartis, NA: Consultancy , Honoraria and Research Funding
Celgene, NA: Honoraria
Chugai, NA: Honoraria and Research Funding
Pfizer, NA: Honoraria and Research Funding
Bristol-meyers squibb, NA: Honoraria and Research Funding
Dainippon-Sumitomo, NA: Honoraria
Nursing and Patient Care Innovations, LLC, Founder and CEO:
Ownership Interest
Jazz Pharmaceuticals, Speaker Bureau:
Honoraria
Epic Systems, none:
Family member
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Funding recipient:
Research Funding
Celgene, Funding recipient: Research Funding
bluebird bio, Inc., Consultant / Funding recipient: Consultancy and Research Funding
Baxalta/Shire, Funding recipient: Research Funding
Biomarin, Funding recipient: Research Funding
Amgen, Funding recipient: Research Funding
La Jolla Pharmaceutical, Funding recipient: Research Funding
Celgene, Funding recipient: Research Funding
bluebird bio, Inc., Consultant / Funding recipient: Consultancy and Research Funding
Baxalta/Shire, Funding recipient: Research Funding
Biomarin, Funding recipient: Research Funding
Amgen, Funding recipient: Research Funding
La Jolla Pharmaceutical, Funding recipient: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Rocket Pharmaceuticals, Consultant; Board of Directors:
Consultancy
and
Member of the Board of Directors
Generation Bio, Consultant; Board of Directors: Consultancy and Member of the Board of Directors, with stock
Orchard Therapeutics, Consultant: Consultancy and Own stock
Orchard Therapeutics, Consultant: Board Member and Consultancy
Rocket Pharmaceuticals, Consultant: Board Member and Consultancy
Generation Bio, Consultant: Board member and Consultancy
4bIOCapital, Board member: Board member
Generation Bio, Consultant; Board of Directors: Consultancy and Member of the Board of Directors, with stock
Orchard Therapeutics, Consultant: Consultancy and Own stock
Orchard Therapeutics, Consultant: Board Member and Consultancy
Rocket Pharmaceuticals, Consultant: Board Member and Consultancy
Generation Bio, Consultant: Board member and Consultancy
4bIOCapital, Board member: Board member
Novartis, Employee:
Salary
Nothing to Disclose
Incyte, Employee:
Salary
Nothing to Disclose
Oncology Nursing Society, Speaker:
Honoraria
Nothing to Disclose
Mustang, Research Funding:
Intellectual Property Rights
,
Research Funding
and
Royalty
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employment:
Ownership Interest
and
Salary
Incyte, None:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Foundation Medicine, Consultant:
Consultancy
Nothing to Disclose
Nothing to Disclose
Amgen Inc., Consultant/advisor:
Honoraria
,
Non-financial
and
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Consulting:
Advisory Board
and
Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kiadis Pharma:
Consultancy
Nothing to Disclose
Nothing to Disclose
Celgene:
Consultancy
Mundipharma: Consultancy
Bristol-Myers Squibb: Consultancy
TG Therapeutics: Consultancy
Seattle Genetics: Consultancy
Mundipharma: Consultancy
Bristol-Myers Squibb: Consultancy
TG Therapeutics: Consultancy
Seattle Genetics: Consultancy
Nothing to Disclose
Juno/Celgene, None:
Advisory Board
,
Intellectual Property Rights
and
Research Funding
Precision Biosciences, None: Advisory Board and Options
Eureka Therapeutics, None: Advisory Board and Options
Caribou Biosciences, None: Advisory Board and Options
Nektar Therapeutics, None: Advisory Board and Research Funding
Aptevo, None: Advisory Board
Juno Therapeutics, Advisory Board Member: Advisory Board , Intellectual Property Rights , Research Funding and Royalty
Nektar Therapeutics, Advisory Board Member: Advisory Board and Research Funding
Eureka Therapeutics, Advisory Board Member: Advisory Board and Ownership Interest
Precision Biosciences, Advisory Board Member: Advisory Board and Ownership Interest
Caribou Biosciences, Advisory Board Member: Advisory Board
Precision Biosciences, None: Advisory Board and Options
Eureka Therapeutics, None: Advisory Board and Options
Caribou Biosciences, None: Advisory Board and Options
Nektar Therapeutics, None: Advisory Board and Research Funding
Aptevo, None: Advisory Board
Juno Therapeutics, Advisory Board Member: Advisory Board , Intellectual Property Rights , Research Funding and Royalty
Nektar Therapeutics, Advisory Board Member: Advisory Board and Research Funding
Eureka Therapeutics, Advisory Board Member: Advisory Board and Ownership Interest
Precision Biosciences, Advisory Board Member: Advisory Board and Ownership Interest
Caribou Biosciences, Advisory Board Member: Advisory Board
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, Research Scientist I:
Salary
Nothing to Disclose
Viracyte, Consultancy:
Consultancy
U
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
V
Nothing to Disclose
GENDX, contracted research:
Research Funding
Moderna TX, contracted research: Research Funding
Moderna TX, contracted research: Research Funding
Nothing to Disclose
Chimerix, Employment:
Salary
BioLineRx Ltd, VP of Medical Affairs:
Ownership Interest
and
Salary
Nothing to Disclose
Fate Therapeutics, Chief Development Officer:
Employee of Fate Therapeutics
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Flagship Ventures, Consultant:
Honoraria
Novartis, Consultant: Honoraria
Evelo, Consultant: Honoraria
Jazz Pharmaceuticals, Consultant: Honoraria
Therakos, Consultant: Honoraria
Amgen, Consultant: Honoraria
Merck & Co Inc, Consultant: Honoraria
DKMS Medical Council, Member: Executive Board Member of the DKMS Foundation
Acute Leukemia Forum, Consultant: Honoraria
Seres Therapeutics, Consultant/IP Licensing: Advisory Board , Consultancy , Honoraria , Intellectual Property Rights , Research Funding and Stock Options
Juno Therapeutics, IP Licensing: Intellectual Property Rights
Novartis, Consultant: Honoraria
Evelo, Consultant: Honoraria
Jazz Pharmaceuticals, Consultant: Honoraria
Therakos, Consultant: Honoraria
Amgen, Consultant: Honoraria
Merck & Co Inc, Consultant: Honoraria
DKMS Medical Council, Member: Executive Board Member of the DKMS Foundation
Acute Leukemia Forum, Consultant: Honoraria
Seres Therapeutics, Consultant/IP Licensing: Advisory Board , Consultancy , Honoraria , Intellectual Property Rights , Research Funding and Stock Options
Juno Therapeutics, IP Licensing: Intellectual Property Rights
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracyte, Equity Ownership:
Ownership Interest
ViraCyte, Co-founder: Consultancy and Ownership Interest
Marker, Co-founder: Ownership Interest
ViraCyte, Co-founder: Consultancy and Ownership Interest
Marker, Co-founder: Ownership Interest
medac GmbH, Investigator:
travel grants to scientific meetings
Lophius Biosciences, independent contractor: Research Funding
Lophius Biosciences, independent contractor: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Fate Therapeutics, consultant:
Honoraria
and
Ownership Interest
Bmogen, consultant: Ownership Interest
Bmogen, consultant: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Amgen, None:
Ownership Interest
and
Speaker's bureau
Takeda, None: Speaker's bureau
Abbvie, None: Ownership Interest
Takeda, None: Speaker's bureau
Abbvie, None: Ownership Interest
Nothing to Disclose
Kite a Gilead Company, Employment:
Ownership Interest
and
Salary
AbbVie, .: Ownership Interest
MRK, .: Ownership Interest
AbbVie, .: Ownership Interest
MRK, .: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Jazz Pharmaceuticals, Employee:
Ownership Interest
and
Salary
Nothing to Disclose
Merck, Grantee:
Research Funding
Pharmacyclics, Grantee: Research Funding
Acerta Pharma, Grantee: Research Funding
Select Immunogenomics, Partner: Ownership Interest
Nanostring, Advisory Board Member: Advisory Board and Consultancy
Pharmacyclics, Grantee: Research Funding
Acerta Pharma, Grantee: Research Funding
Select Immunogenomics, Partner: Ownership Interest
Nanostring, Advisory Board Member: Advisory Board and Consultancy
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celgene, None:
Consultancy
Amgen, None: Consultancy
Janssen, None: Consultancy
Takeda, None: Consultancy
Karyopharm, None: Consultancy
Amgen, None: Consultancy
Janssen, None: Consultancy
Takeda, None: Consultancy
Karyopharm, None: Consultancy
Hospital Israelita Albert Einstein, nurse:
nurse
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
W
Nothing to Disclose
Nothing to Disclose
Ablynx, study PI:
Research Funding
Gilead, Study PI: Research Funding
Gilead, Study PI: Research Funding
Lophius Biosciences, independent contractor:
Research Funding
Magenta Therapeutics, Study Investigator:
Consultancy
and
Research Funding
Novartis, Study Investigator: Research Funding
Novartis, Study Investigator: Research Funding
Nothing to Disclose
Lophius Biosciences, membership on advisory committees or review panels:
Advisory Board
and
Ownership Interest
medac GmbH, Investigator:
travel grants for scientific meetings
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Hospital Israelita Albert Einstein, nurse:
nurse
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Chimerix, NA:
Ownership Interest
Cerus, NA: Ownership Interest
Cambium Medical Technologies, Founder biotech start-up: Advisory Board , Financial Benefit and/or patents , Ownership Interest and Royalty
Amgen, NA: Advisory Board
Celldex, NA: Consultancy
Novartis, NA: Advisory Board and Honoraria
Cerus, NA: Ownership Interest
Cambium Medical Technologies, Founder biotech start-up: Advisory Board , Financial Benefit and/or patents , Ownership Interest and Royalty
Amgen, NA: Advisory Board
Celldex, NA: Consultancy
Novartis, NA: Advisory Board and Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
ViaCord Processing Lab, medical director:
medical director
bioverativ, clinical investigator: Consultancy
bluebird bio, Inc, clinical investigator: Consultancy
AllCells, Inc, medical direactor: medical director
AllCells, Inc, Medical director: medical director
Trucode, Consultant: Consultancy
Editas, Consultant: Consultancy
Sangamo Therapeutics, Consultant: Consultancy
ViaCord Processing Lab, Medical director: medical director
bioverativ, Consultant: Consultancy
bluebird bio, Inc., Consultant: Consultancy
ViaCord Processing Lab, Medical director: Medical director
AllCells, Inc, Medical director: Medical director
bluebird bio, Inc, Consultant: Consultancy
bioverativ, clinical investigator: Consultancy
bluebird bio, Inc, clinical investigator: Consultancy
AllCells, Inc, medical direactor: medical director
AllCells, Inc, Medical director: medical director
Trucode, Consultant: Consultancy
Editas, Consultant: Consultancy
Sangamo Therapeutics, Consultant: Consultancy
ViaCord Processing Lab, Medical director: medical director
bioverativ, Consultant: Consultancy
bluebird bio, Inc., Consultant: Consultancy
ViaCord Processing Lab, Medical director: Medical director
AllCells, Inc, Medical director: Medical director
bluebird bio, Inc, Consultant: Consultancy
Merck and Co, Inc, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Novartis, Speakers Bureau:
Speakers Bureau
Abbvie, Consultancy and Membership on an entity's Board of Directors or advisory committees: Advisory Board and Consultancy
Amgen, Consultant: Consultancy
Jazz, Speakers Bureau: Speakers Bureau
Pfizer, Consultancy and Membership on an entity's Board of Directors or advisory committees: Advisory Board and Consultancy
Abbvie, Consultancy and Membership on an entity's Board of Directors or advisory committees: Advisory Board and Consultancy
Amgen, Consultant: Consultancy
Jazz, Speakers Bureau: Speakers Bureau
Pfizer, Consultancy and Membership on an entity's Board of Directors or advisory committees: Advisory Board and Consultancy
Ansun Biopharma, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Miltenyi Biotec, Received research funding:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Tolero Pharmaceuticals, Inc., Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Janssen Global Commercial Strategy Organization, Employee:
Employee
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, collaborator:
Research Funding
Sanofi, MD:
Advisory Board
and
Research Funding
Juno, MD: Advisory Board
Janssen, MD: Advisory Board , Honoraria and Research Funding
Takeda, MD: Advisory Board and Honoraria
Celgene, MD: Advisory Board , Honoraria and Research Funding
BMS, MD: Advisory Board and Honoraria
Amgen, MD: Advisory Board , Honoraria and Research Funding
Juno, MD: Advisory Board
Janssen, MD: Advisory Board , Honoraria and Research Funding
Takeda, MD: Advisory Board and Honoraria
Celgene, MD: Advisory Board , Honoraria and Research Funding
BMS, MD: Advisory Board and Honoraria
Amgen, MD: Advisory Board , Honoraria and Research Funding
Nothing to Disclose
Kadmon Corporation, LLC, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Shire, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, consulting:
Advisory Board
,
Consultancy
and
Research Funding
Karyopharm, consulting: Advisory Board and Consultancy
Apotex, consulting: Advisory Board and Consultancy
Kite, consulting: Advisory Board , Consultancy and Research Funding
Epizyme, consulting: Advisory Board , Consultancy and Research Funding
Genentech, consulting: Advisory Board and Consultancy
Janssen, consulting: Advisory Board , Consultancy and Research Funding
Celgene, contractor: Research Funding
Karyopharm, consulting: Advisory Board and Consultancy
Apotex, consulting: Advisory Board and Consultancy
Kite, consulting: Advisory Board , Consultancy and Research Funding
Epizyme, consulting: Advisory Board , Consultancy and Research Funding
Genentech, consulting: Advisory Board and Consultancy
Janssen, consulting: Advisory Board , Consultancy and Research Funding
Celgene, contractor: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Reata Pharmaceuticals, Equity ownership:
Ownership Interest
Shire, Research: Research Funding
Leadiant, Research: Research Funding
Amgen, Research: Research Funding
Merck, Research: Research Funding
Daiichi Sankyo, Board of Directors/Advisory Committee: Advisory Board
Shire, Research: Research Funding
Leadiant, Research: Research Funding
Amgen, Research: Research Funding
Merck, Research: Research Funding
Daiichi Sankyo, Board of Directors/Advisory Committee: Advisory Board
Nothing to Disclose
AbbVie, Inc, .:
Research Funding
Genentech, .: Research Funding
Genentech, .: Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
BlueBird Bio, Research Funding:
Research Funding
Orchard Therapeutics, Co-Founder & SAB: Advisory Board
Orchard Therapeutics, Funding: Research Funding
Novartis, Consultant: Consultancy
Alerion Biosciences, Co-Founder: Co-Founder
bluebird bio, NA: Intellectual Property Rights and Research Funding
Orchard Therapeutics, Co-Founder & SAB: Advisory Board
Orchard Therapeutics, Funding: Research Funding
Novartis, Consultant: Consultancy
Alerion Biosciences, Co-Founder: Co-Founder
bluebird bio, NA: Intellectual Property Rights and Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Viracor Eurofins Clinical Diagnostics, employee:
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Ansun Biopharma, Investigator:
Research Grant
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Lophius Biosciences, independent contractor:
Research Funding
Nothing to Disclose
Nothing to Disclose
Altor BioScience Corporation, Previous CEO:
Ownership Interest
Altor BioScience Corporation, previous CEO: Ownership Interest
Altor BioScience Corporation, previous CEO: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Genentech, academic research funding:
Research Funding
Pfizer, academic research funding: Research Funding
Best Doctors, consultant: Consultancy
Takeda, consultant: Consultancy
Pfizer, academic research funding: Research Funding
Best Doctors, consultant: Consultancy
Takeda, consultant: Consultancy
Nothing to Disclose
Lentigen Technology, Employee:
Salary
Nothing to Disclose
Nothing to Disclose
Neon Therapeutics, Founder:
Intellectual Property Rights
and
Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Sr. Associate Scientist, Immunology:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Takeda Oncology, Thailand:
Travel
Nothing to Disclose
medac GmbH, investigator:
travel grants for scientific meetings
X
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kite, Employment:
Salary
Y
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Alpine Immune Sciences, Assoc. Director, Clinical Pharmacology:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Gilead Sciences Inc, PI:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte Corporation, Department Head:
Financial Benefit and/or patents
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Amgen, Honoraria:
Honoraria
Pfizer, Honoraria: Honoraria
BMS, Honoraria and research funding: Honoraria and Research Funding
Novartis, Honoraria and research funding: Honoraria and Research Funding
Specialised Therapeutics Australia, Honoraria: Honoraria
Pfizer, Honoraria: Honoraria
BMS, Honoraria and research funding: Honoraria and Research Funding
Novartis, Honoraria and research funding: Honoraria and Research Funding
Specialised Therapeutics Australia, Honoraria: Honoraria
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, None:
Honoraria
Sanofi, None: Honoraria
Merck, None: Honoraria
Bayer, None: Honoraria
Bristol Myers Squibb, None: Honoraria
Roche, None: Consultancy and Honoraria
Janssen, None: Honoraria
Seattle Genetics, None: Honoraria
Takeda Millenium, None: Honoraria
Celgene, None: Honoraria
Curis, None: Research Funding
Johnson & Johnson, None: Research Funding
Novartis, None: Research Funding
Epizyme, None: Consultancy and Honoraria
Sanofi, None: Honoraria
Merck, None: Honoraria
Bayer, None: Honoraria
Bristol Myers Squibb, None: Honoraria
Roche, None: Consultancy and Honoraria
Janssen, None: Honoraria
Seattle Genetics, None: Honoraria
Takeda Millenium, None: Honoraria
Celgene, None: Honoraria
Curis, None: Research Funding
Johnson & Johnson, None: Research Funding
Novartis, None: Research Funding
Epizyme, None: Consultancy and Honoraria
Amgen, other:
Ownership Interest
Pfizer, other: Ownership Interest
Pfizer, other: Ownership Interest
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Incyte, employee:
Salary
and
stock
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Z
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Life Technologies, licensing agreement:
Royalty
Nothing to Disclose
Kadmon Corporation, LLC, Employee:
Salary
Nothing to Disclose
merck, Grant recipient:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Novartis, Employment:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Celularity, Inc., Chief Scientific Officer:
Financial Benefit and/or patents
,
Intellectual Property Rights
,
Ownership Interest
and
Salary
Amgen Inc., Health Economics Manager:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
core grant. P30 CA008748., Other:
Research Funding
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Abbvie, Medical Director, US Affairs:
Salary
Amgen Inc., Medical Director:
Ownership Interest
and
Salary
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Kariurs, Inc., Medical Director, Clinical Discovery:
Salary
Nothing to Disclose
Takeda, MD:
Advisory Board
and
Research Funding
Celgene, MD: Advisory Board and Research Funding
Janssen, MD: Advisory Board and Research Funding
Celgene, MD: Advisory Board and Research Funding
Janssen, MD: Advisory Board and Research Funding
Nothing to Disclose